State of Medtech

In this episode, David Niewolny, Sr. Director and Global Head of Business Development for Healthcare and Medical at NVIDIA, joins Omar Khateeb to discuss how simulation, AI, open-source development, and GPU-scale computing are changing the way medical robots are built and trained.Healthcare robotics has an experience problem. Anatomy varies between patients, devices bend and interact with tissue, sensors can produce imperfect information, and rare edge cases are difficult to recreate consistently.NVIDIA’s healthcare simulation infrastructure gives developers a virtual environment where these conditions can be varied, repeated, and studied before teams move into expensive hardware-heavy development. David explains why the next frontier is not simply making simulation more visually realistic, but making it physics realistic enough to model anatomy, contact, friction, device behavior, and imaging variability across challenging scenarios. The conversation also explores NVIDIA’s open-source strategy and why shared infrastructure could compress innovation cycles across MedTech. Instead of rebuilding the same foundational tools company by company, teams can focus more attention on clinical problems, proprietary data, workflows, AI applications, and measurable patient or hospital value. Omar and David also unpack the larger move toward software-defined, AI-enabled medical devices, where hardware becomes the foundation for continuously evolving applications, automation, and intelligence.The episode offers a compelling view of how GPU simulation and open infrastructure could accelerate medical robotics while creating an entirely new software layer across the MedTech industry.DISCLAIMERThis podcast is for informational and educational purposes only and is not financial, investment, legal, or medical advice. Views expressed are those of the hosts and guests and do not necessarily reflect State of MedTech LLC. Nothing discussed is a recommendation to buy, sell, or hold any investment or security. Conduct your own due diligence and consult qualified financial, legal, medical, or other professionals before making decisions.Episode Breakdown:00:00 How Nvidia Could Transform Surgical Robotics01:12 Intro + Meet David Niewolny02:03 The Biggest Shift Happening in Surgical Robotics04:19 Why Robots Need More Real World Experience10:22 Market Engineering and MedTech Innovation12:30 Why Nvidia Chose Open Source for Healthcare24:08 The Golden Era of MedTech Innovation27:33 How Nvidia Cut Robotic Training From 5 Hours to 2 Minutes30:20 Could AI Create a New Generation of MedTech Startups?31:59 How AI Could Change MedTech Investing and M&A34:10 What Will Create Competitive Advantage in MedTech?38:34 Nvidia, Edge AI and the Future of Medical Robotics41:02 The Next Frontier in Surgical Robotics41:49 Why MedTech Is Entering a Golden Age42:56 Final Thoughts43:17 OutroAre you a MedTech CEO who needs marketing help to attract investors and grow your sales pipeline? Visit GrowMyMedtech.com to book a free analysis.SUBSCRIBEYouTube: https://www.youtube.com/@thestateofmedtechLinkedIn Newsletter: https://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/FOLLOW THE STATE OF MEDTECHLinkedIn: https://www.linkedin.com/company/thestateofmedtech/Instagram: https://www.instagram.com/stateofmedtech/TikTok: https://www.tiktok.com/@stateofmedtechpodX: https://x.com/stateofmedtechFacebook: https://www.facebook.com/stateofmedtechFOLLOW OMAR M. KHATEEBLinkedIn: https://www.linkedin.com/in/okhateeb/Instagram: https://www.instagram.com/omar.m.khateeb/TikTok: https://www.tiktok.com/@omar.m.khateebX: https://x.com/OmarMKhateebFacebook: https://www.facebook.com/OmarMKhateebWatch Omar’s Market Engineering Training: https://youtu.be/KSy8tZGMfCo?si=WGedZ_VJ1oCkITNfJoin Omar at Medtech CEO Camp in Boston https://www.campcuriae.com/#nvidia #surgicalrobotics #medtech #healthcareai #medicalrobotics

In this solo episode, Omar Khateeb translates some of Uber founder Travis Kalanick’s strongest lessons on fundraising, scale, leadership, and resilience into practical ideas for MedTech founders.The discussion begins with a powerful operating principle: companies can only scale as quickly as their organizations can solve the problems created by growth. FDA clearance, new indications, commercialization, international expansion, and larger sales teams may look like progress, but every milestone also introduces new operational complexity. Omar then examines Travis’s fundraising philosophy and why creating alternatives can matter more than becoming emotionally attached to valuation. For MedTech founders, a dense and deliberate financing process can create urgency, preserve leverage, and help capital fund a stronger strategic position beyond the next regulatory milestone. The episode also explores commercialization efficiency, market belief, ecosystem moats, and why early clinical support should eventually translate into easier adoption, faster training, stronger reference accounts, clearer reimbursement, and lower effort required to generate additional revenue. Omar closes by examining founder resilience through the realities of MedTech, where clinical setbacks, regulatory uncertainty, financing pressure, and long commercialization timelines require founders to tolerate the right forms of adversity while continuing to evolve as leaders.Ultimately, great MedTech companies need to become much larger than their technology by building the organizational, financial, commercial, and psychological capacity required to scale.DISCLAIMERThis podcast is for informational and educational purposes only and is not financial, investment, legal, or medical advice. Views expressed are those of the hosts and guests and do not necessarily reflect State of MedTech LLC. Nothing discussed is a recommendation to buy, sell, or hold any investment or security. Conduct your own due diligence and consult qualified financial, legal, medical, or other professionals before making decisions.Episode Breakdown:00:00 Why MedTech Founders Should Study Uber01:05 Travis Kalanick’s Lessons for MedTech03:35 Your Company Can Only Grow as Fast as It Solves Problems06:18 Why Growth Creates More Complexity08:05 The Founder as Problem Solver in Chief10:58 Finding the Line Between Order and Chaos13:42 How to Avoid Bureaucracy Without Creating Chaos15:34 Fundraising Lesson: Process Over Valuation18:08 How Uber Created Fundraising Leverage22:20 Why Alternatives Give Founders More Leverage26:09 How Uber’s Network Effects Created an Efficiency Edge29:05 The MedTech Version of Uber’s Growth Strategy31:01 Why Market Belief Becomes a Competitive Advantage32:35 Your Real Moat May Be the Ecosystem33:44 The Founder’s Capacity to Handle Adversity36:22 Build the Machine Around the Product37:50 OutroAre you a MedTech CEO who needs marketing help to attract investors and grow your sales pipeline? Visit GrowMyMedtech.com to book a free analysis.SUBSCRIBEYouTube: https://www.youtube.com/@thestateofmedtechLinkedIn Newsletter: https://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/FOLLOW THE STATE OF MEDTECHLinkedIn: https://www.linkedin.com/company/thestateofmedtech/Instagram: https://www.instagram.com/stateofmedtech/TikTok: https://www.tiktok.com/@stateofmedtechpodX: https://x.com/stateofmedtechFacebook: https://www.facebook.com/stateofmedtechFOLLOW OMAR M. KHATEEBLinkedIn: https://www.linkedin.com/in/okhateeb/Instagram: https://www.instagram.com/omar.m.khateeb/TikTok: https://www.tiktok.com/@omar.m.khateebX: https://x.com/OmarMKhateebFacebook: https://www.facebook.com/OmarMKhateebWatch Omar’s Market Engineering Training: https://youtu.be/KSy8tZGMfCo?si=WGedZ_VJ1oCkITNfJoin Omar at Medtech CEO Camp in Boston https://www.campcuriae.com/#medtech #startupstrategy #fundraising #entrepreneurship #travis

In this episode, Dr. Amir Reuveny, Founder and CEO of Wesper, joins Omar Khateeb to unpack why sleep diagnostics are becoming increasingly important as the treatment landscape for sleep apnea expands.Amir shares how watching his father struggle with unrecognized sleep apnea eventually connected with his academic work in flexible electronics, leading him to build technology designed around comfortable, clinical-grade home testing. Wesper’s platform uses flexible body sensors and pulse oximetry while generating respiratory data physicians traditionally relied on sleep laboratories to collect. The discussion explores the rise of GLP-1 therapies, CPAP alternatives, oral appliances, surgical treatments, and why a broader range of therapies is increasing the need for accessible diagnosis and ongoing monitoring.Amir and Omar also examine how sleep care is moving beyond specialized sleep medicine into obesity medicine, primary care, ENT, dentistry, and home-based diagnostics, creating a much larger ecosystem around sleep apnea care. The episode offers a compelling look at how materials science, medical devices, software, and changing treatment pathways could move sleep medicine from isolated testing toward more continuous and personalized care. DISCLAIMERThis podcast is for informational and educational purposes only and is not financial, investment, legal, or medical advice. Views expressed are those of the hosts and guests and do not necessarily reflect State of MedTech LLC. Nothing discussed is a recommendation to buy, sell, or hold any investment or security. Conduct your own due diligence and consult qualified financial, legal, medical, or other professionals before making decisions.Episode Breakdown:00:00 Why 80% of Sleep Apnea Cases Go Undiagnosed01:38 Intro + Meet Amir Reuveny02:47 From Flexible Electronics to MedTech Founder03:44 The Personal Story Behind Wesper05:15 Making Sleep Apnea Testing Easier at Home06:20 How Flexible Electronics Changed Sleep Testing09:11 GLP-1s Are Changing Sleep Apnea Treatment12:08 CPAP, GLP-1s and New Treatment Options13:38 How Wesper Improves At-Home Sleep Testing16:09 Inside the Wesper Sleep Testing System18:14 How Wesper Compares to Traditional Sleep Tests20:02 Commercializing At-Home Sleep Diagnostics20:52 How Wesper Reaches Physicians and Health Systems22:45 Why Sleep Care Is Moving Upstream23:51 The New Wesper Sleep Ecosystem25:45 From One-Night Testing to Continuous Monitoring26:55 Expanding Into Obesity, ENT and Primary Care28:27 ResMed and the Future of Sleep Tech29:47 Could Pharma Acquire a Sleep Tech Company?31:09 New Investors Entering the Sleep Market31:54 What’s Next for Wesper32:28 Final Thoughts32:38 OutroAre you a MedTech CEO who needs marketing help to attract investors and grow your sales pipeline? Visit GrowMyMedtech.com to book a free analysis.SUBSCRIBEYouTube: https://www.youtube.com/@thestateofmedtechLinkedIn Newsletter: https://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/FOLLOW THE STATE OF MEDTECHLinkedIn: https://www.linkedin.com/company/thestateofmedtech/Instagram: https://www.instagram.com/stateofmedtech/TikTok: https://www.tiktok.com/@stateofmedtechpodX: https://x.com/stateofmedtechFacebook: https://www.facebook.com/stateofmedtechFOLLOW OMAR M. KHATEEBLinkedIn: https://www.linkedin.com/in/okhateeb/Instagram: https://www.instagram.com/omar.m.khateeb/TikTok: https://www.tiktok.com/@omar.m.khateebX: https://x.com/OmarMKhateebFacebook: https://www.facebook.com/OmarMKhateebWatch Omar’s Market Engineering Training: https://youtu.be/KSy8tZGMfCo?si=WGedZ_VJ1oCkITNfJoin Omar at Medtech CEO Camp in Boston https://www.campcuriae.com/#sleepapnea #sleeptechnology #medtech #digitalhealth #healthcareinnovation

Watch Omar’s Market Engineering Training: https://youtu.be/KSy8tZGMfCo?si=WGedZ_VJ1oCkITNfJoin Omar at Medtech CEO Camp in Boston. Use code MC1000 for $1,000 off. https://www.campcuriae.com/In this solo episode, Omar Khateeb explains why most MedTech investor decks fail to create conviction and how founders can build presentations that make the market opportunity, adoption path, and use of capital clear.A strong pitch deck is more than a sequence of product, market, competition, team, and financial slides. It is an exercise in market engineering and persuasion. Investors need to see not only that the technology works, but also how the market will understand, adopt, and scale around it.Omar breaks down category design, investor psychology, market readiness, traction, commercialization, competition, business models, and storytelling. He explains how to define what your product replaces, what market shift is underway, why it is happening now, and why your company can lead it.A key lesson is the difference between activity and repeatability. Real traction reveals patterns of demand: similar hospital adoption, rising utilization, recurring revenue, shorter sales cycles, stronger physician advocacy, or customers continuing after an initial study.Learn how to make every slide lead naturally to the investor’s next question and connect each funding round to the evidence your company must create.Disclaimer: This podcast is for informational and educational purposes only and is not financial, investment, legal, or medical advice. The views expressed do not necessarily reflect State of MedTech LLC. Nothing discussed is a recommendation to buy, sell, or hold any investment or security. Conduct your own due diligence and consult qualified professionals before making decisions.Episode Breakdown:00:00 How to Build an Investor Deck That Gets Attention01:12 Intro + Why Investor Presentations Matter02:47 What Founders Need to Know Before Pitching05:01 Why Most Investor Decks Get the Strategy Wrong07:28 How to Move Investors From Uncertainty to Conviction09:18 Market Engineering and the Investor Story11:05 Define the Market Before You Pitch the Product13:25 Why Investors Need a Clear Category15:30 Stop Selling Features and Start Selling Market Change19:15 The Psychology of Attention and Memory21:55 Why Now Is Critical to Your Investor Pitch24:03 Product Market Fit vs Market Readiness26:01 How to Explain Complex MedTech Simply29:12 Show Investors Proof, Not Noise31:04 What Real Traction Looks Like32:23 How to Prove Repeatable Market Demand35:01 What Your Funding Round Should Actually Prove37:05 A Better Way to Present Market Opportunity39:15 How to Position Against Competitors41:16 Turning Adoption Into a Business Model43:43 How Market Signals Show Growing Demand45:12 Sell Investors the Future, Not Just the Product47:10 How to Build a Stronger Team and Funding Story48:18 How Every Investor Deck Should Flow50:01 Final Investor Pitch Lessons51:03 OutroAre you a MedTech CEO who needs marketing help to attract investors and grow your sales pipeline? Visit https://GrowMyMedtech.com to book a free analysis.SUBSCRIBEYouTube: https://www.youtube.com/@thestateofmedtechLinkedIn Newsletter: https://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/FOLLOW THE STATE OF MEDTECHLinkedIn: https://www.linkedin.com/company/thestateofmedtech/Instagram: https://www.instagram.com/stateofmedtech/TikTok: https://www.tiktok.com/@stateofmedtechpodX: https://x.com/stateofmedtechFacebook: https://www.facebook.com/stateofmedtechFOLLOW OMAR M. KHATEEBLinkedIn: https://www.linkedin.com/in/okhateeb/Instagram: https://www.instagram.com/omar.m.khateeb/TikTok: https://www.tiktok.com/@omar.m.khateebX: https://x.com/OmarMKhateebFacebook: https://www.facebook.com/OmarMKhateeb

In this episode, Omar Khateeb speaks with Amy Kruse, General Partner and Chief Investment Officer at Satori Neuro, about the intersection of neuroscience, neurotechnology, AI, brain health innovation, and venture capital.A neuroscientist, DARPA leader, defense executive, entrepreneur and investor, Amy explains Satori Neuro's ecosystem approach. Interests include neuromodulation, precision psychiatry, biomarkers, digital therapeutics, psychedelics, the gut-brain axis, diagnostics and access to care.The conversation explores systems-level neuroscience and targeted interventions such as TMS, tDCS and low-intensity focused ultrasound. Amy shares how imaging, biomarkers, personalized therapies, and neuromodulation could move psychiatry toward care designed around each patient.Omar and Amy also discuss AI brain models, multimodal data, proprietary datasets, defensible platforms, brain-computer interfaces, closed-loop systems, sleep tech, consumer devices, cash-pay care, and pathways that could bring advanced treatments into homes and local clinics.For founders and investors, Amy explains clinical milestones, seed and Series A expectations, tranche financing, investor pitches, market pull, and why excellent science needs a credible commercialization strategy.DISCLAIMERThis podcast is for informational and educational purposes only and is not financial, investment, legal, or medical advice. Views expressed are those of the hosts and guests and do not necessarily reflect State of MedTech LLC. Nothing discussed is a recommendation to buy, sell, or hold any investment or security. Conduct your own due diligence and consult qualified financial, legal, medical, or other professionals before making decisions.EPISODE BREAKDOWN00:00 Why Neurotechnology Is Entering a New Era00:51 Intro + Meet Amy Kruse02:57 From DARPA Neuroscience to Venture Capital07:07 Satori Neuro's Investment Thesis10:05 Market Engineering + MedTech Commercialization13:09 Precision Psychiatry and Targeted Brain Therapies16:29 AI and Foundation Models for the Brain18:27 What Creates a Defensible AI Moat?20:13 Why the US Needs to Invest in Neurotechnology22:34 The Future of Brain-Computer Interfaces25:14 Building the Next Neurotech Giant29:21 Why Neurotech Needs Platform Companies31:30 Brain-Computer Interfaces and Pharma34:14 Why Reimbursement Isn't the Only Path38:08 Bringing Neurotechnology Closer to Patients41:01 What MedTech Founders Need to Know About Fundraising44:10 What Makes an Early-Stage Startup Investable?45:49 Why Great Science Alone Isn't Enough47:14 The Biggest Founder Pitching Mistakes49:38 A Better Way to Pitch Investors53:05 The Wildest Investor Pitch Story54:30 Neuroplasticity and Neuromodulation57:49 Consumer Neurotech and Human Performance01:00:10 Why Consumer Neurotech Hasn't Exploded Yet01:01:23 The Billion-Dollar Opportunity in Sleep Tech01:03:36 Why Neurotech Form Factor Matters01:05:11 Rapid Fire + Amy's Favorite Health Tech01:07:27 The Future of Precision Brain Medicine01:08:58 Final Thoughts01:09:30 OutroAre you a MedTech CEO who needs marketing help to attract investors and grow your sales pipeline? Visit GrowMyMedtech.com to book a free analysis.SUBSCRIBEYouTube: https://www.youtube.com/@thestateofmedtechLinkedIn Newsletter: https://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/FOLLOW THE STATE OF MEDTECHLinkedIn: https://www.linkedin.com/company/thestateofmedtech/Instagram: https://www.instagram.com/stateofmedtech/TikTok: https://www.tiktok.com/@stateofmedtechpodX: https://x.com/stateofmedtechFacebook: https://www.facebook.com/stateofmedtechFOLLOW OMAR M. KHATEEBLinkedIn: https://www.linkedin.com/in/okhateeb/Instagram: https://www.instagram.com/omar.m.khateeb/TikTok: https://www.tiktok.com/@omar.m.khateebX: https://x.com/OmarMKhateebFacebook: https://www.facebook.com/OmarMKhateeb#neurotechnology #brainhealth #neuromodulation #medtech #healthcareinnovation

In this solo episode, Omar Khateeb examines Peter Thiel’s most overlooked lesson for MedTech founders: breakthrough technology does not create its own path to customers, investors, clinicians, or commercial adoption.Drawing from the sales and distribution chapter of Zero to One, Omar explains why commercialization begins long before FDA clearance or product launch. A MedTech company is already selling when it recruits employees, raises capital, engages physician advisors, secures clinical partners, and asks hospitals to support a future that has not yet been fully proven.The discussion explores why genuinely innovative technologies require sophisticated market education, how founders can reduce uncertainty across complex hospital buying decisions, and why technical differentiation must be supported by a credible narrative, economic case, adoption strategy, and distribution model. Omar also examines fundraising, category creation, investor confidence, physician advocacy, early adopters, recruiting, public relations, and market engineering.Ultimately, the episode argues that founders must build belief before they can build revenue. The companies that understand this early create stronger organizations, attract better talent, earn greater investor confidence, and give meaningful healthcare innovation a credible path toward patients.This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.Episode Breakdown:00:00 Why Great MedTech Products Still Fail01:04 Intro + Peter Thiel's Biggest Lesson03:51 Why Every Founder Is Always Selling06:05 Getting Comfortable With Rejection06:58 The Most Overlooked Chapter in Zero to One11:27 Why Market Engineering Matters13:34 If You Build It, Will They Come?15:12 Why Distribution Is Part of Product Design18:05 Why New Categories Need Better Storytelling21:10 The Biggest Sales Mistake MedTech Founders Make24:30 Why Selling Is Really About Building Belief27:10 Your Biggest Competitor Is Doing Nothing31:24 Market Engineering Starts Before Launch32:45 Why Founders Must Sell to Investors and Employees34:47 The Hidden Power of PR and Reputation38:05 The First Thing You Sell Is Belief39:38 Final Lessons From Zero to One41:00 OutroAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb#medtech #startupstrategy #marketanalysis #gotomarket #peterthiel

Michael Minogue, 2026 Republican Endorsed Candidate for Governor of Massachusetts, President and CEO of Minogue Consulting, and former CEO of Abiomed, joins Omar Khateeb to share the leadership principles behind one of MedTech's most remarkable growth stories.The conversation explores how Abiomed evolved from a struggling company into a $17 billion MedTech leader by creating an entirely new category around heart recovery rather than competing within an existing market. Michael explains how leadership, commercialization, physician adoption, innovation, culture, disciplined execution, and patient first thinking combined to establish a new global standard of care while delivering extraordinary clinical and business outcomes. Together, they discuss category leadership, cardiovascular innovation, crisis management, organizational culture, regulatory strategy, data driven improvement, leadership under pressure, talent development, servant leadership, and why the greatest healthcare companies are built by leaders who remain obsessed with continuous improvement, long term value creation, and patient impact.This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.Episode Breakdown:00:00 How Abiomed Became a $17 Billion MedTech Success01:23 Intro + Meet Former Abiomed CEO Mike Minogue04:30 The Vision That Changed Abiomed Forever08:41 Why Heart Recovery Beat Heart Replacement12:20 Creating a New Standard of Care14:39 Building the Heart Recovery Category16:47 Engineering a Market, Not Just a Product17:06 Learn, Adapt, Execute21:54 How Data Improved Patient Survival25:25 The Hardest Leadership Lesson26:20 Ranger School and Building Mental Toughness31:20 Surviving a Two Year Attack on the Company34:05 Turning Crisis Into Competitive Advantage37:52 Why Mike Chose Public Service41:18 Running a State Like a Business44:54 Leadership, Service, and the Future of Massachusetts46:46 One Message for Every Entrepreneur48:00 OutroAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb#heartrecovery #medtech #medicaldevices #leadership #healthcareinnovation

In this episode, Omar Khateeb explores why commercialization is not a launch event but a long-term process of engineering market belief. Strong technology, FDA clearance, clinical validation, and venture funding reduce technical risk, yet they do not guarantee that physicians, investors, or strategic acquirers will change their behavior. The discussion introduces the principles of Market Engineering, the Traction Gap, and Category Design, explaining how successful MedTech companies deliberately build credibility, investor confidence, physician advocacy, and repeatable adoption before expecting commercial scale. Omar also examines why category leaders capture the majority of economic value, why attention should never be confused with adoption, and why defining the market is often more valuable than competing inside someone else's category. Whether you're a founder, executive, investor, or commercialization leader, this episode offers a strategic framework for creating stronger market positioning, accelerating clinical adoption, and building sustainable MedTech growth.This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.Episode Breakdown:00:00 Why Most MedTech Startups Fail After Raising Capital01:03 Intro + Why Great Technology Still Struggles02:35 When Commercialization Really Begins04:28 The Biggest Risk Most Founders Ignore06:48 Why Great Products Still Fail in the Market08:52 Product Engineering vs Market Engineering11:10 The Traction Gap Every Founder Must Understand13:08 Why Raising Money Doesn't Prove Market Demand15:00 Repeatable Traction vs One-Time Success17:12 Attention Is Not Adoption19:02 Why Category Leaders Capture Most of the Market21:05 Build a Category Before You Build Demand23:02 Why Category Design Determines Who Wins24:37 Final Takeaways25:00 OutroAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb#medtech #startupstrategy #category #gotomarket #healthcareinnovation

The future of healthcare may be shaped less by incremental innovation and more by technologies that fundamentally change how we understand the human brain.In this episode, Omar Khateeb is joined by Brom Rector, Founder of XEIA Venture Partners, and Samantha Rector, General Partner of XEIA Venture Partners, for an in-depth conversation about neurotechnology, AI, longevity, venture capital, and the Human 3 vision for the future of medicine.They explore why neuroscience represents one of healthcare's largest unmet opportunities, how AI is accelerating biological discovery, why brain computer interfaces and neuromodulation are attracting serious investment, and how rigorous scientific thinking separates durable innovation from industry hype.The discussion also covers commercialization, preventative healthcare, lifestyle medicine, founder psychology, venture investing, and why tomorrow's healthcare leaders may build technologies that don't simply treat disease but elevate human health itself.This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.Episode Breakdown:00:00 Why We Still Know So Little About the Brain01:27 Intro + Meet the XEIA Ventures Team02:26 From Drug Discovery and Quant Finance to Venture Capital05:08 Why They Left Traditional Careers to Build a Fund08:06 Building a Public Investment Thesis Through Content10:38 Why a Husband and Wife Built a Venture Fund Together14:44 Family Businesses, Long-Term Thinking, and Generational Wealth17:15 How XEIA Expanded Beyond Psychedelics19:11 The Human Three Manifesto Explained22:52 Investing Beyond Disease Toward Human Performance28:08 Lifestyle Medicine and the Massive Opportunity in Healthcare30:24 Will Consumers Choose Medical Devices Like They Choose Wearables?44:44 The Most Exciting Investments in XEIA's Portfolio47:05 The Untapped Opportunity in Sexual Health Innovation50:05 Why Nontraditional Healthcare Markets Create Massive Companies53:10 How XEIA Evaluates Founders and Breakthrough Technologies01:01:32 The Biggest Mistakes Founders Make When Raising Capital01:05:26 Where Neurotechnology and AI Are Headed Next01:09:08 Why This Is the Best Time to Build in Healthcare01:12:08 Final Advice for Founders and Investors01:13:00 OutroAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb#neurotechnology #brainhealth #mentalhealthinnovation #medtech #healthcareinnovation 

Click here to get the 2026 H1 HSBC Report https://www.marketcraft.ai/resources/hsbc-venture-healthcare-report-2026In this episode, Omar Khateeb sits down with Henry Peck of LSI and Jon Norris, Managing Director of HSBC Innovation Banking, to analyze the H1 2026 Mid Year Healthcare Venture Trends Report and explain what today's healthcare investment landscape means for founders, investors, executives, and innovators building the future of MedTech.The conversation goes beyond headline funding announcements to examine the deeper signals driving healthcare venture capital. Together, they discuss the record pace of healthcare investment, MedTech financing, AI adoption, diagnostics, neurotechnology, cardiovascular innovation, commercialization, IPO activity, strategic acquisitions, and the changing expectations investors now place on emerging healthcare companies. Henry also shares insights from LSI's proprietary market intelligence and Compass AI platform, explaining how healthcare venture trends, investor behavior, commercialization milestones, and financing dynamics may shape the industry's next phase of growth. Whether you're raising capital, evaluating investment opportunities, or leading healthcare innovation, this episode provides valuable perspective on where healthcare venture is heading after H1 2026.This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.Episode Breakdown:00:00 - Introduction & HSBC Healthcare Report Overview01:28 - Episode 400 Celebration & Guest Intro05:19 - Key Industry Trends in H1 Venture Healthcare13:02 - Market Engineering & Growth Strategies16:02 - Cardiovascular Funding Paradox & Financing Bottlenecks17:11 - John Norris on First-Financing Gaps & PMA Track Deals20:37 - Structural Risks in MedTech Series B Funding25:41 - Sector Spotlight: Neuro Growth vs. Cardiovascular Signals33:29 - John Norris on Exit Windows & M&A Recovery46:55 - John Norris on Evolving Investor Preferences & Milestone Expectations55:56 - John Norris on Undervalued Opportunities: Imaging + AI01:01:30 - Reimbursement Arcs & Clinical Adoption Challenges01:05:45 - John Norris’s Bold 2026 M&A Predictions01:12:27 - 2026 Market Outlook: Winner-Take-All Dynamics01:18:35 - Final Takeaways & Wrap-UpAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb#medtech #healthcareinnovation #medicaldevices #healthtech #venturecapital

Innovation rarely arrives through incremental improvements.It emerges when industries become willing to fund thousands of parallel experiments around a shared vision of the future.In this solo episode, Omar Khateeb explores why productive bubbles have repeatedly accelerated humanity's greatest technological breakthroughs and why MedTech may need its own period of ambitious experimentation to unlock the next generation of category defining companies.Drawing lessons from semiconductor history, Silicon Valley, structural heart, robotics, AI, and healthcare, Omar explains why bubbles should be measured by the infrastructure, knowledge, talent, and capabilities they leave behind rather than the valuations they temporarily create.The discussion also covers the J curve of innovation, category design, market engineering, venture capital, ecosystem building, and why the companies that redefine industries begin by changing beliefs before changing products.This episode presents a strategic framework for founders, investors, and MedTech leaders looking to build markets that shape the future instead of simply improving the present.This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.Episode Breakdown:00:00 Why Bubbles Drive Innovation01:06 Intro + Why MedTech Needs More Bubbles03:50 Vision Before Innovation05:09 Why Progress Slows Down08:32 Why Innovation Comes in Waves12:25 Why Markets Must Be Engineered15:26 The J Curve of Breakthrough Innovation19:20 Why Every Breakthrough Looks Irrational22:08 The Hidden Value of Productive Bubbles25:07 Parallel Experiments Build the Future28:02 Why Ecosystems Beat Individual Companies30:18 Failure Creates Future Winners33:55 Why MedTech Needs More Experimentation39:38 Optimization vs Reinvention43:58 Purpose Drives Breakthrough Innovation46:06 The Innovation Flywheel Explained49:17 Final Takeaways50:00 OutroAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb#medtech #innovation #startupstrategy #futureofhealthcare #category

Building the Intelligence Platform for Modern Surgery.The next breakthrough in surgery may not come from another robot. It may come from intelligence.In this episode, Omar Khateeb speaks with Peter Verrillo, CEO of Redefine Surgery, about building the technology platform that brings computer vision, Physical AI, and world models into the operating room.Peter shares why Collaborative Surgical Intelligence creates a different path than autonomous surgery, how AI mentors can preserve the expertise of master surgeons, and why understanding movement, anatomy, and surgical judgment requires far more than large language models.The conversation also explores how enabling technologies create stronger long-term value than standalone products, why open surgery represents one of healthcare's largest untapped AI opportunities, and how partnering directly with medical device companies accelerates adoption across the industry.This episode delivers strategic insight into where surgical innovation, artificial intelligence, and MedTech platform companies are heading next.This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions. Episode Breakdown:00:00 Why AI Needs to Move Beyond Surgical Robots00:52 Intro + Meet Peter Verrillo03:29 Why Open Surgery Has Been Left Behind07:04 Collaborative Surgical Intelligence Explained10:14 Why Autonomous Surgery Isn't the Goal12:01 Why Markets Must Be Engineered15:10 The Opportunity in Open Orthopedic Surgery17:05 What Makes Redefining Surgery Different?20:19 Why Tech Talent Is Transforming MedTech24:01 The Nvidia Business Model for Surgery27:06 How Medical Device Companies Benefit29:36 How Redefine Can Challenge Industry Leaders31:38 Training AI With the World's Best Surgeons34:49 Physical AI and World Models Explained37:09 Revenue Before Commercialization40:10 Why Traditional MedTech Is Falling Behind44:02 The Economics of Surgical Robotics46:11 The Long Term Vision for Redefine Surgery49:26 Why AI Investors Are Looking at MedTech50:00 OutroAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb#surgicalinnovation #medtech #healthcareinnovation #medicaldevices #artificialintelligence

Winning markets rarely begins with building a better product.It begins with changing how customers think.In this solo episode, Omar Khateeb explores why category design is the first discipline of Market Engineering and how market leaders consistently create new buying frameworks before competitors recognize the opportunity.Using examples from Tesla, Red Bull, Intuitive Surgical, and the Play Bigger methodology, the conversation explains why categories organize buyer perception, attract ecosystems, influence capital, and ultimately determine where profits accumulate.Omar also shares practical strategies for defining category boundaries, building stronger market narratives, creating differentiated positioning, and engineering belief through repeatable systems rather than relying on product features alone.This conversation offers a strategic playbook for leaders who want to move beyond building better products and start building categories that define the future of their markets.This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.Episode Breakdown:00:00 Why the Best Product Doesn't Win01:00 Category Design Explained03:09 Red Bull and the Power of Category Creation04:13 Why Markets Follow Narratives, Not Products06:08 Product Engineering vs Market Engineering08:34 Why the Brain Organizes Everything Into Categories10:47 The 76% Rule Behind Category Leaders13:11 Intuitive Surgical and the Da Vinci Playbook15:00 Category Design vs Market Engineering16:07 Better Isn't Enough Be Different18:42 The 5-Layer Category Design Framework21:11 Why Great Categories Exclude Competitors23:27 The Three Documents Every Founder Needs25:57 How Markets Move From Skepticism to Belief27:58 Building an Ecosystem That Compounds Growth29:46 Winning With a New Frame Instead of Better Features31:05 The Biggest Lesson Every Founder Should Remember33:00 OutroAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb#category #marketleadership #startupstrategy #medtech #businessgrowth

Enterprise AI: Why the Interface Matters More Than the Mode!Most conversations about artificial intelligence focus on models.The real transformation is happening somewhere else.In this episode, Omar Khateeb welcomes Harry Glorikian, General Partner at Scientia Ventures, to discuss how invisible interfaces, AI agents, enterprise workflows, and organizational redesign are changing the future of business.The discussion covers AI native companies, software abstraction, healthcare transformation, physician workflows, regulatory innovation, trust architecture, enterprise productivity, and why memory driven systems may become every executive's most valuable operating layer.Harry also explains why management teams should rethink competitive advantage, organizational design, customer engagement, and decision making before competitors move first.This conversation delivers practical insights into the strategic changes every leadership team should already be planning.This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions. Episode Breakdown:00:00 Why AI Is Changing Business Forever01:14 Intro + Harry Glorikian's Journey04:08 Why Management Needs a New AI Strategy07:22 The Founder Liquidity Fund08:08 The Invisible Interface Explained10:14 AI as Your Personal Operating Layer13:18 The Three AI Breakthroughs15:27 Why AI Is Advancing So Fast17:49 Enterprise AI and Personal Workflows22:36 AI's Impact on MedTech and Healthcare25:39 Software Becomes the Real Competitive Advantage26:12 Proof in Seconds and Cognitive Atrophy32:32 Building Better AI Workflows34:26 AI, Jobs, and the Future of Work36:07 The New Competitive Moats39:13 AI Search Is Changing Buying Decisions42:48 The Power of AI Defaults44:14 Choosing the Right AI Models47:14 Harry's AI Tech Stack50:21 AI for Finance, Research, and Presentations53:15 Why CEOs Must Lead AI Strategy55:08 The Biggest Risk for MedTech Leaders57:00 Key Takeaways From The Invisible Interface59:00 OutroAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb#artificialintelligence #medtech #businessstrategy #futureofwork #digitaltransformation

This Month in MedTech What the Biggest MedTech Deals Reveal About the Future of Healthcare.June delivered one of the clearest signals yet about where MedTech strategy is heading.In this episode, Omar Khateeb speaks with Henry Peck, Chief Business Officer at LSI, about the deals, investment patterns, and strategic decisions defining the current MedTech market.The discussion covers Medtronic’s two same-day ICE catheter investments across California and Shenzhen, Edwards Lifesciences’ move to own both surgical and transcatheter options in tricuspid, Contraline’s major financing in male contraception, and the accelerating use of AI to predict market movement before it becomes obvious.The episode also explores why cardiovascular innovation continues attracting concentrated capital, why neuromodulation remains one of the most active areas in MedTech, and why companies that own the full patient pathway may gain stronger strategic advantage.This conversation offers a clear market intelligence briefing for anyone watching the business of healthcare innovation.This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.Episode Breakdown:00:00 Why $6.5 Billion in MedTech Deals Changes Everything01:06 Intro + This Month in MedTech03:21 Q2 MedTech Deal Flow Overview06:18 Why Capital Is Concentrating in Cardiology08:54 Neuromodulation and AI Investment Trends10:59 Medtronic's $6.5B M&A Strategy15:15 Why Medtronic Is Betting on ICE Catheters20:57 Medtronic's Bigger Cardiac Play22:40 The Future of Cardiac Ablation24:50 Edwards' Tricuspid Valve Strategy27:18 Owning the Entire Patient Pathway31:22 Why Investors Backed Male Contraception37:16 Compass AI Prediction Agent42:10 AI's Boldest MedTech Predictions48:37 Speed Round on the Biggest June Deals54:49 Key Takeaways for MedTech Leaders56:00 Final Thoughts + OutroAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb#medtech #medicaldevices #healthcareinnovation #cardiovascularhealth #medtechindustry

The Infrastructure Behind Intelligent Medical Devices.Medical innovation is becoming increasingly intelligent.The infrastructure supporting those devices must evolve just as quickly.In this episode, Omar Khateeb speaks with Omari Bouknight, CEO & Board Director of Resonant Link Medical, about the role wireless power will play in the future of implantable healthcare.The conversation covers rechargeable medical devices, brain-computer interfaces, AI-enabled implants, cardiac rhythm management, smart sensing, MRI compatibility, and why traditional battery technologies are approaching their practical limits.Omari also shares why enabling technologies create value across entire industries, how wireless energy transfer supports the next generation of intelligent devices, and why the companies building foundational infrastructure often influence healthcare long before products reach the market.This discussion offers valuable insights for founders, investors, engineers, clinicians, and MedTech leaders preparing for the next wave of healthcare innovation.This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.Episode Breakdown00:00 Why Wireless Power Could Transform MedTech01:33 Intro + Omari Bouknight's Background05:08 From Guidant to Abbott to Resonant Link09:40 Why Wireless Power is the Next MedTech Platform13:28 The Battery Problem in Implantable Devices16:05 Why Rechargeable Implants Matter18:13 Pacemakers, Neurotech, and Smart Implants20:56 The Origin of Resonant Link Medical24:22 Why AI Needs More Power in Medical Devices27:13 How Wireless Charging Actually Works29:51 Charging Brain Computer Interfaces33:03 Which Medical Devices Need the Most Power?36:57 The Next Wave of MedTech Innovation41:47 Consumer Health Meets Implantable Devices45:29 The Future of FDA and Consumer MedTech48:32 Why Nvidia Could Shape Healthcare's Future50:13 The Biggest Market Opportunity for Wireless Power54:16 When MedTech Founders Should Partner with Resonant Link56:21 How Startups Discover Resonant Link58:18 Why Wireless Power is Still a Blue Ocean01:00:39 Why MedTech is Harder to Disrupt Than Software01:01:17 What's Next for Wireless Power Technology01:02:30 Final Thoughts and Where to Learn More01:03:41 OutroAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb#medtech #medicaldevices #wirelesscharging #neurotech #healthcareinnovation

Why Product Market Fit Is Only the Beginning!Most startups spend years chasing traction.Very few spend enough time understanding what happens after they achieve it.In this solo episode, Omar Khateeb explains why product-market fit creates opportunity but does not create protection. Growth attracts customers, but it also attracts competitors, capital, strategic interest, and market attention.The conversation explores category leadership, market control, ecosystem building, narrative ownership, flywheel economics, and why sustainable advantage comes from shaping the environment around a category rather than simply participating in it.Omar also shares practical lessons from MedTech, software, AI, and platform businesses that demonstrate why the companies that create categories are not always the companies that ultimately dominate them.A powerful discussion on strategy, competitive positioning, and long-term market leadership.This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.Episode Breakdown:00:00 Why Traction Can Be Dangerous01:08 Intro + The Real Purpose of Traction03:15 Why Most Startups Fail05:00 Traction vs Category Leadership06:30 Growth Creates Visibility and Competition09:40 Why Growth Is Exposure, Not Protection12:46 Market Share vs Category Control14:53 The Power of Narrative Control18:13 Building an Ecosystem Moat21:20 The Capital Flywheel Explained23:05 Why Standards Create Market Power25:09 How Challengers Beat Market Leaders27:23 Early Signs of Commoditization29:20 Why Category Leadership Must Be Managed31:00 Two Companies, Two Different Outcomes32:06 Final Lessons on Traction and Leadership33:00 OutroAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb#medtech #category  #marketleadership #startupstrategy #businessgrowth #leadership

Most surgical innovation focuses on what happens during or after a procedure.Saahil Mehta believes the bigger opportunity may exist before surgery ever starts.In this episode, Omar Khateeb speaks with the Founder of Plexāā about prehabilitation, tissue conditioning, breast reconstruction, patient education, and the role preparation plays in long-term recovery.The discussion examines how heat shock proteins can improve tissue resilience, why surgical complications often delay treatment, and how structured preparation programs can give patients more control over their outcomes.Saahil also shares how Plexāā is combining medical devices, digital health, and behavioral engagement to build a new category around surgical readiness.Healthcare has spent decades optimizing recovery.Preparation may be the next frontier.This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.Episode Breakdown:00:00 Why Surgery Recovery Starts Before Surgery00:01 Intro + The Problem with Pre-Op Care02:00 From Plastic Surgeon to MedTech Founder04:45 Why Patients Ask the Same Question Before Surgery06:58 The Hidden Problem in Breast Reconstruction09:00 What is Skin Necrosis?11:15 How Delayed Healing Impacts Cancer Treatment12:30 The Science of Heat Shock Proteins14:45 The Origin of Bloom4316:50 How the Device Works18:25 Why Prehabilitation Matters20:56 The Free Bloom43 App Explained22:19 The Story Behind the Bloom43 Name24:15 Why Patients Only Use It the Night Before Surgery26:03 Why a Heating Pad Isn't the Same Thing28:07 Commercial Launch and Patient Access30:20 Hospital Adoption and Future Reimbursement33:16 Clinical Evidence and Ongoing Research36:10 Mayo Clinic Collaboration and C-Section Expansion38:00 Why Women's Health is the Perfect Beachhead40:37 AI, Patient Data, and Personalized Surgical Prep42:46 Wearables, Recovery, and the Future of Surgery44:42 Building the Future of Pre-Op Care47:00 What's Next for Plexo and Bloom4348:15 Final Thoughts49:00 OutroAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb#breastcancer #medtech #surgicalinnovation #healthcareinnovation #womenshealth

In this solo episode, Omar Khateeb explores why many startups struggle immediately after gaining traction.The challenge is rarely the technology.The challenge is the buyer.Early adopters and mainstream customers make decisions for completely different reasons. One group rewards innovation and vision. The other rewards certainty, references, evidence, and proven outcomes.The conversation examines the psychology behind technology adoption, the importance of reference customers, the power of focus, and why credibility becomes the most valuable asset when companies attempt to cross the chasm.Omar also explains how trust compounds, why broader markets often slow growth, and how market leadership is built through density rather than reach.A practical framework for founders, operators, investors, and commercial leaders navigating the journey from adoption to scale.This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.Episode Breakdown:00:00 Why Most Startups Fail After Early Success01:03 Intro + Crossing the Chasm Explained03:15 The Technology Adoption Curve05:50 Innovators vs Mainstream Buyers08:40 Why Better Products Still Fail11:20 The Early Adopter Trap13:00 Why Product-Market Fit Isn't Enough15:15 Market Engineering Before Launch17:30 Selling Vision vs Selling Proof20:10 The Bowling Alley Strategy22:00 Why Focus Beats Going Broad24:15 Building Trust Through References26:00 The Whole Product Concept28:20 Why Mainstream Buyers Resist Change30:10 Chasm Readiness Checklist31:45 Scaling Trust and Reducing Risk33:00 The One Segment Strategy34:06 Final Thoughts + OutroAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb#medtech #gotomarket #chasm #startupstrategy #marketexpert

Omar Khateeb speaks with Nishant Doctor, Founder, CEO, and CTO of Surf Therapeutics, about the next frontier of neurotechnology: using ultrasound neuromodulation to target inflammation.Nishant breaks down the science behind the cholinergic anti-inflammatory pathway, why the splenic nerve may offer a more direct target than the vagus nerve, and how non-invasive stimulation could create a different treatment path for rheumatoid arthritis patients.The episode also covers capital efficiency, first-in-human studies, patient usability, autoimmune disease, and why Surf is focused on building a therapy that could be safer, easier, and more accessible than invasive alternatives.A powerful conversation on bioelectronic medicine, chronic disease, and the future of non-invasive MedTech.This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.Episode Breakdown00:00 How One Minute of Stimulation Can Reduce Inflammation01:34 Intro + Why Drug Alternatives Matter03:23 Nishant Doctor’s Journey Into Neuromodulation05:23 Neuromodulation vs Neurotechnology Explained08:15 Neuralink, BCI, and the Rise of NeuroTech09:07 Building Through Market Cycles13:37 The Origin Story of Surf Therapeutics15:23 Inflammation, Healthspan, and Chronic Disease17:52 The Science Behind the Anti-Inflammatory Pathway18:50 Why Vagus Nerve Stimulation Works20:18 Why Surf Chose a Non-Invasive Approach21:31 The Problem with Current Treatment Options22:44 Going Directly to the Splenic Nerve24:26 Vagus Nerve Side Effects Explained26:03 Biohacking, Longevity, and Vagus Nerve Devices27:15 How Surf’s Technology Works29:40 Capital Efficiency and Startup Execution32:02 Why Testing Beats Product Perfection33:58 Build Fast, Test Fast, Learn Fast37:20 Why Rheumatoid Arthritis Was the First Target39:38 The Rheumatoid Arthritis Opportunity40:02 Understanding Rheumatoid Arthritis41:38 Expanding Beyond a Single Disease43:31 The Future of Inflammation Therapy44:55 Why the Company is Called Surf46:16 Clinical Progress and Upcoming Milestones48:02 Strategic Interest and Future Opportunities48:38 OutroAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb#neurotech #neuromodulation #rheumatoidarthritis #medtech #healthcareinnovation

The Psychology of Startups vs Corporations. In this solo episode, Omar Khateeb examines the hidden forces that shape career satisfaction, professional growth, and long term success.Using the Barbarians to Bureaucrats framework, the conversation explores how organizations evolve through different stages and why each stage attracts a different type of personality. Visionaries, builders, operators, administrators, and executives all create value, yet many professionals struggle because they find themselves working inside environments that conflict with how they naturally think and operate.Omar shares lessons from MedTech, entrepreneurship, and company building to explain why startups reward ownership, adaptability, and comfort with uncertainty while larger organizations reward process, specialization, and scalable execution. The discussion also highlights how organizational mass impacts decision making, why bureaucracy exists, and how understanding these dynamics can dramatically improve career choices.Career fulfillment often begins when personality and environment finally align.This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.Episode Breakdown00:00 Why Your Next Career Move Might Be Wrong00:01 Intro + The Career Question Everyone Asks02:00 Barbarians to Bureaucrats Framework Explained04:15 Corporate Life Cycles and Personality Fit06:35 Prophet, Barbarian, Builder, and Bureaucrat08:45 Why Some People Thrive in Startups11:10 The Physics of Company Growth13:40 Why Large Companies Move Slower16:05 Process vs Innovation18:20 Startup Chaos vs Corporate Structure20:30 Are You a Startup Person or a Corporate Person?22:15 Why Bureaucracy Exists23:50 The Biggest Career Mistake Professionals Make25:10 Finding the Right Stage of Company Growth26:30 How to Evaluate Your Next Opportunity27:45 The Intuitive Surgical Lesson28:35 Where Do You Belong on the Curve?29:00 Final Thoughts on Career GrowthAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb#careergrowth #leadershipdevelopment #startuplife #medtech #professionaldevelopment

Why Great Markets Create More Value Than Great Products!In this episode, Omar Khateeb speaks with Bruce Cleveland, Chief Executive Officer of Traction Gap Partners and author of Market Engineering, about one of the most overlooked drivers of company success: market creation.Drawing from his experience helping build Oracle, Siebel Systems, and C3 AI, Bruce explains why many companies focus heavily on product engineering while overlooking the discipline required to engineer markets. The conversation covers category design, strategic positioning, messaging, storytelling, thought leadership, and the role these elements play in creating lasting competitive advantage.Bruce also shares why category leaders often capture the majority of market value, how founders can measure market momentum before revenue appears, and why market leadership requires far more than a superior product.For anyone building a company, launching a new category, or trying to create durable market leadership, this episode provides a practical blueprint for shaping demand, influencing industry conversations, and driving long term growth.This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.Episode Breakdown: 00:00 The $1.3 Billion Mistake and Lessons From Silicon Valley01:54 Intro + Bruce Cleveland's Background04:37 Oracle, Apple, and Siebel Systems08:50 Building Category-Defining Companies12:35 Why Most Startups Fail15:49 Market Problems vs Sales Problems18:54 The Story Behind Traction Gap22:26 Why Bruce Wrote Market Engineering23:48 What is Market Engineering?27:26 The Five Pillars of Market Engineering34:41 Why Great Products Still Fail36:31 Market Engineering vs Demand Generation39:27 Early Signals That a Market Is Forming42:00 Why Market Engineering is the CEO's Job44:59 Thought Leadership in MedTech46:18 The Three Core Market Engineering Artifacts49:04 Building a Category Others Want to Join52:40 Category Leadership and Competitive Advantage54:27 Why Early Adopters Matter57:12 Creating a Single Source of Truth01:00:20 AI, Search, and the Future of Market Visibility01:03:50 AI-Powered Market Engineering Tools01:06:46 Aligning Teams Around a Market Strategy01:09:15 Final Thoughts on Market Leadership01:11:00 OutroAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb#marketexpert #startupstrategy #medtech #b2bmarketing #thoughtleadership

In this episode of This Month in MedTech, Omar Khateeb speaks with Nicholas Talamantes, Sr. Director at Life Science Intelligence, about the market signals shaping MedTech right now.The discussion covers Q1 earnings from major strategics, the rise of focused growth platforms, Boston Scientific’s $1.5B bet on structural heart, and the latest M&A activity from J&J, Medtronic, ResMed, Roche, and Artivion.Omar and Nicholas also break down why focus is being rewarded in public markets, why large platforms are divesting non-core assets, and how commercial proof, option structures, and tuck-in acquisitions are shaping the next wave of MedTech deals.A must-listen for anyone tracking MedTech growth, healthcare M&A, cardiovascular innovation, AI diagnostics, surgical robotics, and the strategic decisions defining the next market cycle.This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.Episode Breakdown00:00 Why Focused MedTech Companies Are Winning00:02 Intro + This Month in MedTech02:03 Q1 Earnings Overview and Market Trends03:54 AI Hype vs Healthcare Revenue Reality05:40 What Q1 Earnings Tell Us About MedTech07:36 Why Focus Beats Diversification08:55 Edwards Lifesciences' Strong Quarter10:14 Intuitive Surgical's Growth Engine11:01 Insulet’s 34% Growth Story12:52 Why Insulet’s Stock Fell Anyway23:39 Medtronic’s Return to Aggressive M&A24:53 J&J’s Cardiovascular Growth Strategy25:39 Abbott’s Cardiovascular Momentum26:12 Why Cardiovascular Is Dominating MedTech29:01 Key Takeaways From Q1 Earnings30:43 Boston Scientific’s $1.5B Structural Heart Bet31:48 Boston’s Third Attempt at TAVR37:47 J&J Acquires Atraverse Medical47:53 Is MedTech Entering an M&A Boom?49:40 Artivion Buys Endospan51:43 Medtronic Acquires SPR Therapeutics53:17 M&A Trends and Strategic Optionality55:38 Why More Acquisitions May Be Coming57:58 The Rise of Option-Based Deal Structures01:00:35 Speed Round: Notable Funding Deals01:01:00 Butterfly Medical $21M Series C01:02:27 SonoMind $23.5M Series A01:03:45 Aidoc Raises $150M01:05:30 Illuminant Surgical $8.4M Seed01:08:06 Perimeter Medical $10.5M Financing01:10:15 AI, Cancer Care, and Clinical Impact01:13:05 Biggest Lessons From May 202601:17:10 Final Thoughts on Focus, Growth, and M&A01:22:00 OutroAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb#medtech #healthcareinnovation #medicaldevices #digitalhealth #medtechinnovation

In this episode, Omar Khateeb speaks with Matt Curl, Chief Executive Officer at Apollo.io, about AI native go to market systems, modern revenue growth, and why great products rarely win markets on their own.Matt shares how Apollo.io built one of the leading go to market platforms serving hundreds of thousands of businesses worldwide and explains why modern GTM now depends on real time data, automation, customer intelligence, AI driven personalization, and unified commercial execution.The discussion explores account based marketing, product market fit, commercialization strategy, customer acquisition, and why most companies still operate fragmented revenue organizations without a single strategic owner driving the system.The episode also dives into MedTech commercialization, physician adoption behavior, category positioning, and why the strongest companies create belief, distribution, and narrative before the market fully understands the product itself.A must-listen for founders, commercial leaders, operators, investors, and teams building scalable growth engines in the AI era.This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions. Episode Breakdown:00:00 Why the First 10 Sales Don’t Matter00:40 Intro + Matt Curl, CEO of Apollo.io02:01 What Apollo Does and Why It Matters03:14 What is Go-To-Market (GTM)?05:18 The Four Pillars of Modern GTM08:25 Why Only a Few Thousand Companies Do GTM Well09:50 COVID, AI, and the Evolution of GTM11:01 Why the Best Product Doesn't Always Win13:10 Market Engineering vs Sales Problems21:18 Category, Messaging, Narrative, and GTM22:06 Product-Market Fit vs Messaging Failures24:53 AI and the Future of Personalized GTM34:43 Why Messaging Determines Adoption36:18 Product-Market Fit vs Market-Product Fit39:21 How to Find Early Adopters41:48 What MedTech Gets Wrong About GTM44:42 Why Relationships Aren’t a Scalable Moat45:54 The Difference Between 10 Sales and 10,000 Sales46:36 Why AI Can’t Fix Broken Fundamentals48:59 The Real Metric That Matters50:46 The One Trait Shared by Great GTM Teams51:57 Who Should Own Go-To-Market?53:18 Why Data-Driven Leaders Win54:22 Building a Unified GTM System56:10 Why Winning Customers Creates Winning Companies58:05 Final GTM Advice for Founders and CEOs59:29 OutroAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb#gotomarket #b2bsaas #revenueoperations #salesleadership #apolloio #medtech

In this episode, Omar Khateeb explores the Elephant Slide framework and why it is becoming an essential leadership tool in MedTech boardrooms.The discussion breaks down why disconnected operational updates often create fragmented board conversations around clinical milestones, financing, regulatory progress, commercialization, and market confidence. Omar explains how strong CEOs use strategic narrative to help investors understand what the updates actually mean before uncertainty starts filling the room.Inspired by RA Capital’s SABER framework, the conversation also explores investor psychology, fundraising readiness, commercialization strategy, market engineering, and why the best MedTech leaders connect evidence, adoption, cash runway, and long term company value into one clear story.A must-listen for founders, executives, investors, and operators navigating complex growth environments in healthcare innovation.This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.Episode Breakdown00:00 Why Board Meetings Go Wrong00:36 What is an Elephant Slide?00:57 Intro + Why This Matters for CEOs01:13 Why You Should Watch This Episode01:14 The Origin of the Elephant Slide02:30 Why Most Board Decks Fail04:00 The Real Problem in Board Meetings05:40 Why CEOs Must Control the Narrative06:30 The Blind Men and the Elephant Story08:10 Why Board Members Get Confused09:25 The Fictional “Neo” MedTech Example10:15 Why Data Alone Creates Anxiety11:17 What Board Members Are Really Thinking14:32 The “Bottom Line First” Framework16:00 Why Context Matters More Than Updates17:30 How Enrollment Delays Affect Financing18:45 Market Engineering and Board Communication20:00 Why FDA Clearance Isn’t Enough21:00 The Most Important Slide in Every Board Deck22:10 Strategy vs Operations vs Housekeeping23:00 Why Great CEOs Control the Narrative23:58 Final Advice for Your Next Board Meeting24:40 Outro + Subscribe25:18 EndAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb#boardmeetings #medtech #startupleadership #venturecapital #healthcareinnovation

In this episode, Omar Khateeb speaks with Deborah K. and Virginia Giddings of Edwards Lifesciences about the future of MedTech innovation, venture capital, and strategic investment.The conversation explores why great technology and clinical superiority alone rarely create adoption in MedTech. Topics include startup failure rates, acquisition pathways, AI-enabled robotics, minimally invasive therapies, strategic partnerships, healthcare platforms, and the system-level barriers shaping modern healthcare innovation.A sharp discussion for founders, investors, operators, and MedTech leaders building technologies that must scale beyond the product itself.This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.Episode Breakdown00:00 Why Most MedTech Startups Fail00:14 The Long Path of MedTech Innovation01:01 Intro + Virginia Giddings and Deb Kilpatrick02:14 VP of Exploration at Edwards Explained03:26 Sonder Capital’s Investment Thesis05:10 Why Transformational Healthcare Matters06:12 Why Industry Leadership Matters07:44 Healthcare is Personal for Everyone09:09 Venture Capital vs Strategic Investors10:32 Why MedTech Needs a Symbiotic Ecosystem12:21 Why MedTech is Worth the Risk13:34 Organic vs Inorganic Innovation15:40 Why FDA Clearance Isn’t Enough18:55 Robotics, AI, and the Future of Investing26:44 Why MedTech Still Struggles to Attract Capital28:33 Product Superiority vs Clinical Superiority30:34 Why MedTech is Harder Than SaaS31:05 AI is Reshaping Healthcare33:14 Why Great Devices Still Fail Adoption37:56 AI Native Companies vs AI Features38:53 AI, Robotics, and Human Performance40:30 AI Safety Loops in Therapeutics41:12 AI Imaging and Automated Diagnosis43:22 Consumer Health Data Platforms Explained45:00 Why MedTech Needs Bigger Bets46:49 BCI, Consumer Health, and Future Platforms48:17 Why Healthcare Innovation Needs Systems50:05 Consumers Are Taking Control of Healthcare52:55 Cash Pay Healthcare and Insurance Friction54:04 The Medicare Demographic Shift58:41 Healthcare Savings and Consumer Empowerment59:20 One Policy Change That Could Transform Healthcare01:00:50 Maternal Health and Early Intervention01:03:02 Rethinking Medicare for the Future01:06:10 Final Thoughts on Innovation and Healthcare01:18:00 OutroAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb#medtech #healthcareinnovation #artificialintelligence #digitalhealth #venturecapital

In this solo episode, Omar Khateeb explores the psychology of winning companies through the lens of barbarians, bureaucrats, and hardball strategy.The episode connects lessons from Rome, Alexander the Great, Ray Kroc, Steve Jobs, Elon Musk, Intuitive, and MedTech startups to explain why speed, urgency, and conviction often beat comfort and process. Omar also breaks down why barbarian energy is powerful early, why it must evolve as companies scale, and how organizations can preserve competitive intensity without falling into chaos.Books referenced in this episode include Hardball by George Stalk and Barbarians to Bureaucrats by Lawrence M. Miller, two frameworks that heavily shaped the conversation around competitive intensity, organizational decay, and market conquest.This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.Episode Breakdown:00:00 Why Great Companies Become Weak01:12 Intro + Barbarian Leadership Explained03:20 Crossing the Chasm and Corporate Lifecycles05:45 Founder Mode vs Bureaucracy08:00 What is a Barbarian in Business?10:00 Why Startups Beat Large Corporations12:10 Prophet vs Barbarian Leadership Styles14:30 Intuitive Surgical and MedTech Conquest16:50 Why the Market Rewards Aggression18:45 Steve Jobs and the Reality Distortion Field21:00 Why Bureaucracy Kills Innovation23:20 IBM, Comfort, and Corporate Decline25:00 Barbarian Traits: Speed, Urgency, Conviction27:10 Why Simplicity Beats Complexity29:00 Rome vs Attila the Hun31:45 Why Civilizations Collapse Internally First34:00 Alexander the Great and Organizational Power36:40 Elon Musk and Barbarian Leadership39:00 Why Speed is a Competitive Weapon41:15 Hardball Strategy Explained43:00 Principle 1: Overwhelming Competitive Force45:00 Principle 2: Exploit Competitor Weakness47:00 Principle 3: Take Innovation and Scale It49:00 Principle 4: Force Competitors to Retreat50:50 Principle 5: Break Industry Assumptions52:30 Why Founders Struggle to Scale Companies54:20 Barbarian Energy vs Organizational Systems55:40 Why Competitive Advantage Never Lasts56:50 How Companies Lose Their Hunger57:35 Final Thoughts on Leadership and Competition58:40 OutroAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb#medtech #leadership #startupstrategy #foundermode #businessgrowth #elonmusk #tesla #apple

In this episode, Omar Khateeb speaks with Chris Darland, President & CEO of Peerbridge Health, about the future of AI driven cardiac intelligence and preventive heart care. Peerbridge Health is building a platform designed to move cardiology from reactive intervention toward earlier detection through wearable ECG technology, software intelligence, and high fidelity cardiac data.Chris explains how most monitoring systems today focus mainly on arrhythmia detection, while Peerbridge is building toward a broader intelligence layer capable of identifying myocardial stress, structural defects, sleep related issues, and cardiac deterioration much earlier. The discussion also explores AI defensibility in MedTech, why proprietary data matters, how health systems could use intelligent triage tools to route patients faster, and why the future of cardiology may depend on scalable preventive infrastructure.This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.Episode Breakdown00:00 Why Cardiac Care is Still Reactive00:53 Intro + Chris Darland and Peerbridge Health02:00 Growing Up Around Heart Disease04:30 From GE to MedTech Startup CEO05:20 The Real Problem in Cardiology Today06:49 Scaling Cardiac Care Beyond Hospitals08:00 Heart Failure and Readmission Crisis09:00 Arrhythmia Monitoring Explained10:00 Beyond Arrhythmias: Structural Heart Detection12:00 AI + ECG for Earlier Detection13:58 Why Most MedTech Startups Fail After FDA14:05 Cardiac Intelligence Platform Explained16:00 Using ECG Data to Detect Heart Disease Early18:00 Why Signal Fidelity Matters19:30 AI Layer for Personalized Cardiac Insights23:00 Why Hardware + Unique Data Matter24:08 Regulatory Strategy and FDA Pathway27:30 NASA Signal Processing and SpaceTech Crossover29:15 Strategic Partnerships and Acquisition Potential31:00 Detecting Patients Before Critical Events33:35 AI Triage for Primary Care and Cardiology36:00 Reducing Unnecessary Specialist Visits37:39 Using AI to Route Patients to the Right Hospital39:00 Fundraising and Strategic Investors41:00 Clinical Trials and Real-World Evidence43:14 Early Trial Results and Heart Failure Detection44:09 The Future of AI-Powered Cardiac Care45:25 Why Mission Matters More Than Exit Price47:40 OutroAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb#cardiology #medtech #aiinhealthcare #digitalhealth #healthcareinnovation

In this episode, Omar Khateeb explores the hidden infrastructure behind AI, media, and markets: attention.The discussion traces how Google organized attention through PageRank, how social media platforms monetized it through engagement systems, and how AI models now operationalize it through transformer architectures built around attention mechanisms. Omar also dives into the psychology of focus, the economics of outrage, and why modern algorithms reward visibility over truth. From Elon Musk’s first-principles focus to market engineering and narrative design, the episode connects attention to everything from founder execution to cultural influence.At its core, this is a conversation about leverage.Where attention goes, energy flows and markets follow.This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.Episode Breakdown00:00 Attention is the Foundation of AI and Modern Life01:15 Intro + Why Attention Matters03:00 Attention Shapes Reality05:17 The Brain’s Spotlight Effect07:20 Depression, Love, and Attention Patterns08:45 The Magnifying Glass Analogy10:05 Why Focus Creates Extraordinary Results11:00 Elon Musk, Bottlenecks, and Concentrated Attention14:28 Your Life Reflects What You Feed Attention To15:00 Chamath Palihapitiya’s Attention Theory16:05 How Google Organized Human Attention18:00 Social Media Monetized Attention19:30 Why Algorithms Reward Outrage and Fear21:00 “Attention Is All You Need” Explained22:10 How AI Uses Attention Mechanisms23:00 AI, Transformers, and Machine Attention23:46 Attention vs Truth25:20 Why Society Focuses on the Wrong Problems27:00 The Psychology of Polarization and Virality28:30 Why Young People Want to Become Influencers29:46 Attention, Outcomes, and the Process31:00 Why Great Founders Focus on Process32:15 Flow States and Deep Work33:35 Parenting, Presence, and Attention34:30 Marketing is About Directing Attention35:30 Perception, Meaning, and Repetition37:00 Why Repetition Creates Belief39:00 Attention Engineering in Marketing40:15 Why Most Marketing Fails41:00 Audit Your Attention This Week42:50 Final Thoughts on AI, Attention, and Reality44:03 OutroAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb#artificialintelligence #attentioneconomy #marketingpsychology #personalgrowth #futureofa

In this episode, Omar Khateeb sits down with Fazila Seker, CEO and Board Director of Insight Medbotics, to explore how meaningful MedTech innovation starts by solving real clinical problems.Fazila shares how her team uncovered a major gap in prostate cancer care by closely observing how physicians use MRI today. That insight led to the development of an MRI-native platform designed to unify diagnosis and treatment into one precise workflow.The conversation covers the limitations of fusion-based systems, the value of exact spatial data, and how a connected data layer can improve targeting, outcomes, and future AI-driven insights.A sharp look at how market-driven thinking turns clinical needs into real innovation.This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions. Episode Breakdown:00:00 Why MRI Could Transform Prostate Cancer Care01:08 Intro + Fazila Seker Background01:54 From PhD Chemist to MedTech Founder03:41 Why Healthcare Innovation Matters More04:53 Why MedTech is Harder Than Tech Startups06:14 Fall in Love With the Customer, Not the Technology07:10 Why Physicians Resist New Technology07:57 Building Molli Surgical Through Market Validation09:18 Molli Surgical Explained11:23 Getting Acquired Before FDA Clearance13:58 Why Most MedTech Startups Fail After FDA15:52 Market Engineering vs Traditional Go-To-Market17:27 Why Market Pull Matters in MedTech18:28 Inside Insight Medbotics20:39 Why MRI Native Robotics Matters22:57 MRI Limitations in Prostate Cancer Today23:33 Product-Market Fit vs Market-Product Fit24:40 Physician “Hacks” Reveal Market Opportunities32:22 Why Fusion Imaging Falls Short33:43 FDA Challenges of MRI Robotics34:22 Diagnosis + Treatment in One Platform35:25 Building a Closed-Loop MRI Data Platform36:29 The Future AI Layer for Predictive Care37:56 GPS for Prostate Cancer Explained40:22 Strategic Partners: Intuitive, J&J, Medtronic42:40 Future of Drug Delivery and Precision Oncology44:10 Transformative Innovation vs Incremental MedTech45:49 Why Healthcare Rewards Incremental Innovation50:14 Why Startups Fail Without Market Need51:20 The Problem With “Me Too” MedTech Companies53:25 Why Transformational Thinking Wins54:13 Fundraising, AUA, and What’s Next for Insight55:50 OutroAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb#medtech #prostatecancer #medicalimaging #healthcareinnovation #surgicalrobotics 

In this episode of This Month in MedTech 2026, April brings a sharper look at where the market is heading.The discussion covers Medtronic’s $100M investment in Pulnovo, why denervation may be turning into a platform strategy, and how China market access could become a bigger part of global MedTech dealmaking. The episode also unpacks Q1 funding trends, cardiovascular M&A, and key deals across thrombectomy, oncology, metabolic disease, lung cancer, and wearable robotics. The bigger message is clear: capital is still moving, but it is becoming more strategic.This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.Episode Breakdown:00:00 Q1 2026 MedTech Funding Drops Explained00:55 Intro + This Month in MedTech02:13 Q1 2026 Funding Recap04:14 Why Capital Deployment Slowed Down06:10 Mega Rounds Decline Explained06:58 Early Stage MedTech Funding Still Stable07:46 MarketCraft Ad: Engineering Market Pull11:01 LSI Alumni and Early Stage Funding Trends12:01 Cardiovascular M&A Momentum13:22 Stryker’s Surprise Cardiovascular Strategy15:48 Endovascular Robotics and Platform Wars18:36 IVL Market Growth + Strategic Acquisitions19:59 Medtronic’s $100M Bet on Pulnovo21:00 Why Medtronic is Suddenly Aggressive22:11 Boston Scientific vs Medtronic Strategy24:33 Future of Early Stage MedTech Investing25:54 AI in MedTech Companies27:17 Pulnovo Technology Explained28:38 China Market Access Strategy30:38 Platform Strategy in MedTech32:46 Deals and Dollars Speed Round33:21 Cala Health $50M Growth Round34:03 Calyxo $40M Series F Explained35:25 Endovascular Engineering $80M Series C39:20 Sonera Therapeutics Series A40:27 Endogenex and Metabolic Device Innovation43:02 GLP-1 Drugs vs Device-Based Therapies44:25 Hepa Medical Lung Cancer Technology45:21 Wearable Robotics and Exoskeleton Market47:34 Biggest Takeaways from April 202648:49 Why Platform Companies Are Winning49:40 Free Trial for Compass AI51:07 Final Thoughts + Outro  Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb#MedTech #HealthcareInnovation #MedicalDevices #VentureCapital #DigitalHealth

In this episode, Omar Khateeb speaks with Nick Damiano, CEO and Co-Founder of Andromeda Surgical, about how autonomous surgery could redefine surgical robotics.Nick shares how Andromeda is approaching the market differently by focusing on software, autonomy, and real-world surgical data rather than building another traditional robotics platform. The discussion covers their first beachhead in urology, why HoLEP is a powerful starting point, and how better automation could close the gap between novice and expert surgeons.They also explore founder mode in MedTech, why software scales differently than hardware, and how AI-driven robotics could create a new era of surgery for patients, surgeons, and hospitals. This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisionsEpisode Breakdown:00:00 Autonomous Surgery Vision and Why It Matters01:08 Intro + Nick Damiano and Andromeda Surgical02:19 Founder Background and Journey into MedTech04:32 Why Build Autonomous Surgical Robotics06:20 Identifying the Right Beachhead Market (Urology)08:27 Why Not Compete with Existing Surgical Robots10:13 Why Most MedTech Startups Fail (Market Problem) 13:27 Inside “Beacon” Platform: Software-First Approach15:31 How the System Works in Real Procedures17:08 Why Software is the Real Advantage (Not Hardware)18:48 TechMed vs MedTech: Choosing the Right Strategy20:39 Software Scale vs Hardware Limits Explained22:20 Why Incumbents Will Struggle to Adapt23:43 Hiring Philosophy: Mindset Over Experience25:51 Why MedTech Struggles to Attract Top Talent28:18 Founder Mode vs Traditional CEO Model30:27 Why Founder-Led Companies Win32:16 Hiring for Slope vs Skillset Explained33:05 Building High-Performance Teams36:21 Clinical Progress + Commercialization Strategy38:35 Why Utilization Matters More Than Revenue40:50 Redefining Surgical Robotics Category43:12 Why Autonomy Will Transform Healthcare45:42 How the AI System is Trained (Data + Feedback)47:32 Future of Surgery: Outcomes, Access, Scale49:55 Where to Find Andromeda + Closing Thoughts51:00 OutroAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠#medtech #surgicalrobotics #aiinhealthcare #healthcareinnovation #digitalhealth

In this episode, Omar Khateeb, Founder of Marketcraft, shares a focused breakdown of how MedTech companies build toward strong exits. Based on $17B in acquisition insights, this solo episode reframes exits as outcomes of deliberate strategy, not last-minute negotiations. Omar highlights how founders create leverage through early acquirer relationships, clear category positioning, and sustained market presence. He also explains why competitive tension matters, how timing impacts value, and why clinical clarity plays a central role in decision-making. If you want a sharper understanding of how MedTech exits actually happen, this episode gives you a clear and actionable perspective.This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.Episode Breakdown:00:00 Why Most MedTech Exits Fail (No One Finds You)00:59 Intro + $17B in Exit Lessons Explained02:30 Lesson 1: Acquirer Relationships Take Years05:30 Why Visibility and Narrative Matter08:00 Lesson 2: The Power of Not Needing to Sell10:30 Why 85% of Deals Have Only One Buyer 12:44 Market Problem vs Product Problem14:18 Strategic Investors Can Reduce Leverage16:30 Lesson 3: Hard Endpoints vs Surrogate Metrics19:30 Why Clinical Data Drives Acquisitions21:53 Lesson 4: Investigators as Strategic Assets24:30 Why Skeptics Are More Valuable Than Believers27:00 Lesson 5: Acquirer Culture Matters More Than Price30:00 Post-Acquisition Success vs Deal Size31:30 Lesson 6: Phase 2 Data = Maximum Leverage34:00 Timing Your Exit for Maximum Value35:30 Lesson 7: CEO Resilience Drives Exit Outcomes37:12 Final Thoughts + Founder Mindset37:49 OutroAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb#medtech #mergersandacquisitions #startupstrategy #venturecapital #healthcareinnovation 

In this episode, Omar Khateeb speaks with Dennis McWilliams, Managing Director at Santé Ventures, about what makes a medtech company investable at the early stage.From building Apollo Endosurgery to leading venture investments, Dennis shares how Santé evaluates market size, clinical risk, valuation, and exit potential. He also explains why founders should engage investors early and how disciplined capital strategy shapes outcomes.The episode highlights companies like Farapulse, Laminar, Endogenex, and Sonire Therapeutics, and the role of strategics like Medtronic, Boston Scientific, and Johnson and Johnson in driving acquisitions and growth.A focused look at how medtech capital really moves.This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.Episode Breakdown:00:00 Harsh Truth About Startup Failure and Capital Risk00:12 Corporate Venture vs Traditional VC01:05 Intro + Dennis McWilliams (Sante Ventures)02:26 Dennis Background: From Aerospace to MedTech06:05 Why MedTech is Harder Than SaaS08:04 Lessons from Fund IV and Market Cycles11:51 Investment Strategy: Early Stage Focus13:58 Why Valuation Discipline Matters 16:31 Why Sante Stays Early Stage18:01 Early vs Late Stage Investing Tradeoffs21:21 Notable Wins: Cardiovascular and M&A Success23:32 What Makes a Winning MedTech Company23:39 Sante Investment Filter Explained26:06 Evaluating New Markets and White Space28:05 How VCs Find Startups30:00 Advice for Founders Raising Capital33:12 Minimum Requirements to Pitch a VC35:41 Founder vs Experienced CEO Debate39:52 When Founders Get Replaced42:22 What VCs Look for in Founders43:48 Corporate Venture Capital Explained46:32 Risks and Dynamics of Corporate Investors48:00 Founder Mistakes with Equity48:56 Why Dilution is Misunderstood51:51 Biggest Startup Mistakes (Valuations)53:00 How Long VC Decisions Really Take56:13 New Investment Spotlight (Oncology)57:36 Rapid Fire: Learning Venture Capital01:00:01 How Venture Really Works Behind the Scenes01:02:00 OutroAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb#medtech #venturecapital #startupfunding #healthcareinnovation #entrepreneurship

In this episode, Omar Khateeb, Founder of Marketcraft, takes a focused look at technology adoption and what it really takes to move from early traction to mainstream scale. This solo conversation highlights why many companies gain initial momentum but struggle to sustain growth.Omar explains the shift from vision-driven early adopters to pragmatic mainstream buyers, and why this transition requires more than a strong product. He breaks down the importance of category clarity, repeatable systems, and structured demand creation in driving real adoption. If you want a sharper understanding of how growth actually happens in MedTech, this episode gives you a clear and actionable perspective.Episode Breakdown:00:00 Why Most Startups Fail After Early Traction00:46 Early Adopters vs Early Majority Explained01:07 Intro + What is Technology Adoption02:30 Crossing the Chasm Framework Explained04:30 Technology Adoption Curve Breakdown06:30 Early Market vs Mainstream Market09:00 Psychology Shift: Vision vs Pragmatism11:30 Why Early Traction Doesn’t Scale13:58 The Traction Gap Explained 16:00 Minimum Viable Category (MVC) Concept18:30 Market-Product Fit vs Product-Market Fit21:00 Why Messaging Breaks in the Chasm23:30 Signs You're Stuck in the Chasm25:30 Repeatability vs Scaling Explained27:30 Beachhead Strategy (D-Day Analogy)30:00 Category, Messaging, Narrative Framework32:30 Why Sales and Marketing Fail Without Systems34:30 How to Cross the Chasm Successfully36:23 Final Takeaways + Founder Advice37:00 OutroAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateebThis podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions#technologyadoption #startupstrategy #medtech #marketanalysis #productmarketfit

In this episode, Omar Khateeb sits down with Kyle Dempsey, Partner at MVM Partners, to unpack what makes a medtech company investable. Kyle shares how MVM evaluates opportunities, why commercial traction matters, and what separates strong companies from those that get overlooked. They also explore how strategics think about acquisitions, why differentiation and market size matter, and how investors assess risk across the commercialization journey. If you want a clearer understanding of medtech investing, commercialization, and exits, this episode delivers exactly that.Episode Breakdown:00:00 Why MedTech Wins: Innovation vs Big Strategics01:04 Intro + Kyle Dempsey (MVM) Background02:13 Journey: From Medical School to Investing06:50 What is MVM and How the Fund Evolved09:41 Portfolio Highlights + Biggest Wins10:59 Fund Strategy: High Conviction Investing12:24 What MVM Avoids: DTC and Weak Models13:58 Why Most MedTech Startups Fail 16:22 DTC vs B2B Economics in Healthcare17:25 Why Esthetics is a Tough Category19:12 What Makes a Great MedTech Company23:03 Evaluating Competitive Markets25:49 Winning in Competitive Categories27:38 Sales Model + Market Size Reality29:01 Why Big Markets Attract Acquirers30:56 MedTech Exit Trends + M&A Outlook33:44 IPO Market vs Acquisition Strategy36:58 What LPs Care About (DPI vs IRR)40:07 Fast Returns vs Long-Term Outcomes41:41 Why Traction Matters More Than Ever44:33 Bad MedTech Models That Still Get Funded46:20 Small Markets vs Scalable Opportunities48:37 TAM vs SAM vs Real Market Potential51:35 BCI and Neurotech: Hype vs Reality55:48 MVM Investment Stage + Check Size01:00:28 AI in MedTech: Feature vs Platform01:04:25 AI Business Model Challenges01:07:30 Final Thoughts + Future of MedTechAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateebThis podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions#medtech #venturecapital #healthcareinnovation #startupstrategy #medicaldevices

In this episode, Omar Khateeb, Founder of Marketcraft, unpacks the real reason most MedTech startups fail to gain traction. This is not a product problem. It is a market problem.He explains how market engineering helps founders define categories, create demand, and move from early innovation to scalable growth. The conversation covers the traction gap, why product market fit is incomplete, and how unclear positioning leads to failed fundraising and slow adoption. If you want a clearer understanding of traction, commercialization, and growth in MedTech, this episode delivers exactly that.Episode Breakdown00:00 Why 95% of Startups Fail (It’s Not the Product)01:21 Intro + What is Market Engineering02:00 The Real Problem: Market vs Product Failure04:30 Why Great Products Still Fail06:30 The Myth of “Build It and They Will Come”08:30 Product Market Fit is Incomplete10:30 Defining Market vs Product Fit12:00 The Traction Gap Explained14:30 Why Startups Get Stuck Before Scaling17:00 Minimum Viable Category (Where It All Starts)19:30 Why Most MedTech Has “No Market”22:00 Product vs Market Failure (Critical Difference)24:00 What Real Traction Actually Means26:30 Early Signs of Real Demand28:30 Why Launch Hype ≠ Market Validation30:00 Why Sales and Marketing Won’t Fix This31:30 Market Engineering Framework (Core Formula)33:30 Category, Messaging, Narrative, Go-To-Market35:00 Common Founder Mistakes36:30 Final Advice: Control Your Category37:36 Outro + SubscribeAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtech⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠X ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://twitter.com/StateofMedTech⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Facebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Follow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@omarkhateebofficial⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠X ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://twitter.com/OmarMKhateeb⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Facebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions#medtech #startupstrategy #marketanalysis #healthcareinnovation #venturecapital 

In this episode, Omar Khateeb sits down with Lana Ghanem, VP of Corporate Development & Ventures at Hikma Pharmaceuticals and Managing Director at Hikma Ventures, to unpack how corporate venture is reshaping MedTech.This is not just about capital. It is about how corporate venture teams think, how they assess opportunities, and why most companies never make it past the first conversation.Lana explains why strong traction alone is not enough, and how founders who understand strategic alignment and investor priorities create a clear advantage. The conversation also touches on Hikma’s focus on AI diagnostics, drug development, and scaling healthcare solutions across global markets, especially in the Middle East and North Africa. If you are raising or planning to, this gives you a clearer view of what investors are actually looking for.Episode Breakdown:00:00 Middle East Healthcare Reality + Antibiotic Misuse Problem00:45 Investor Mindset: Why Your Pitch Must Make Sense00:52 AI Diagnostics and Early Screening Trends01:23 Intro: Rise of Corporate Venture in MedTech02:13 Alana Ghanem Background and Career Path12:00 Why Startups Fail: Market vs Product12:30 MarketCraft Ad: Market Engineering for Founders14:59 Board Seat vs Observer Seat Explained16:37 What Investors Look for Beyond Metrics17:45 Founder Mistakes and Importance of Preparation19:51 US vs Global Expansion Strategy20:30 Drug Delivery Innovation and 505(b)(2) Strategy21:30 AI in Drug Development: Where Pharma is Heading23:49 AI Use Cases Beyond R&D (Legal, Ops, Efficiency)25:42 AI Diagnostics and Early Disease Detection26:20 Antimicrobial Resistance Challenge in MENA27:17 Scaling Challenges in MedTech and AI Platforms28:49 Advice for Founders: Make It an Easy Yes30:00 Investor Expectations and Decision Process31:07 How to Reach Hikma Ventures31:44 Conferences and Networking Opportunities32:02 Final Thoughts on Pharma + MedTech Convergence33:00 Outro and SubscribeAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateebThis podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions #medtech #healthcareinnovation #digitalhealth #aiinhealthcare #healthtech

See why medical sales teams are getting more done and closing deals thanks to a proactive AI assistant named Donna. Click here to see how Donna can level up your repshttps://www.askdonna.com/industry/medical-devices?utm_source=state_of_medtechIn this episode, Omar Khateeb speaks with George Murgatroyd of Medtronic about the shift toward a digitized operating room. They explore how AI, connected systems, and platforms like Touch Surgery are improving workflows, training, and performance insights. The conversation also covers robotics, data integration, and why interoperability is key to the future of surgery.Episode Breakdown:00:58 Introduction to OR Digitization and AI in MedTech02:03 George Murgatroyd Background and Career Journey04:10 Music, Creativity, and Early Career Paths06:00 From NHS to Medtronic Digital Innovation08:16 The Future of Healthcare and Technology Shift10:07 Why MedTech Is Falling Behind in AI Adoption20:25 Can AI Reduce Healthcare Costs While Improving Quality22:49 Platform vs Ecosystem Thinking in MedTech26:29 Building Digital Surgery Products at Medtronic28:53 How Surgeons Actually Learn and Improve Today29:08 The Technology Behind Surgical Data and Insights32:00 SaaS in MedTech and Business Model Evolution44:23 Live Streaming Surgery and Training the Next Generation46:52 The Talent and Capital Crisis in MedTech50:34 Ethics, Patients, and Limits of Surgical Broadcasting53:45 How MedTech Can Attract Top Talent56:16 Why Mission Still Matters in MedTech Careers59:02 Apple, Innovation, and Lessons for MedTech01:01:15 Build vs Buy vs Partner in Digital Health01:08:16 AI for Surgical Safety and Real-Time Decision Support01:09:37 Will AI Guide Surgeons Like GPS01:10:05 Why High-Volume Procedures Will Lead AI Adoption01:12:28 Complex vs High-Volume Surgery Debate01:15:30 Which Surgical Specialties Will Adopt AI First01:17:24 The Next Generation of Surgeons and Digital Expectations01:20:06 Final Thoughts and Future of MedTech01:20:30 Music Recommendation and Closing01:21:52 Outro and SubscribeAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateebThis podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions#medtech #healthcareinnovation #medicaldevices #healthtech #startupfunding

In this episode, Omar Khateeb sits down with Raymond W. Cohen of Spiro Medical and Thomas A. West of Nalu Medical to unpack the real difference between innovation and iteration in medtech.Drawing from billions in exits and decades of experience, they explain why most companies fall into the trap of incremental thinking and why that approach is becoming harder to fund. The conversation highlights how venture capital behavior has shifted, why larger rounds are often necessary earlier, and how founders need to rethink how they approach building and scaling their companies.They also explore the importance of narrative, not just having a strong technology, but being able to clearly articulate the full journey from idea to commercialization, including reimbursement, manufacturing, and exit strategy.This episode challenges the way most founders think about growth and offers a clearer path to building something that actually stands out.Episode Breakdown:00:00 Why MedTech Innovation Needs a Reset01:34 Intro + The Big Question06:24 MDM West Opening10:28 Meet Ray Cohen and Tom West12:18 What Happens After an Acquisition?14:49 Why VCs Chase Faster Returns18:36 Raise More Capital, Not Less22:27 Why Great Boards Win24:52 Moonshots vs Incremental Innovation27:40 Why Big MedTech Buys, Not Builds30:08 Strategic Investors Are Back32:35 Think Bigger, Raise Bigger34:08 Why Me Too Startups Fail38:29 Building a Winning Market Narrative40:33 Design for Manufacturing From Day One43:09 Raising $67M for Breakthrough Innovation47:28 What Investors Really Want50:18 Reimbursement Can Make or Break You53:56 The New Fundraising Playbook57:52 IPO vs Acquisition Strategy01:00:21 Learning From iRhythm's Success01:03:05 Audience Q&A01:08:45 AI, Big Tech, and the Future of MedTech01:12:05 Final Advice for Founders01:14:00 Helping Millions of Patients01:16:00 OutroAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateebThis podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions#medtech #healthcareinnovation #medicaldevices #healthtech #startupfunding

In this episode, Omar Khateeb speaks with Nicholas Talamantes about the key medtech shifts shaping Q1 2026. They discuss rising M&A activity, the growing neurovascular arms race, and how robotics is evolving to meet ASC demand. The conversation also covers why strategic buyers are prioritizing precision over scale, along with insights on commercialization, investor expectations, and what startups must demonstrate to show real market traction.Episode Breakdown:00:00 Opening Hook: MedTech Market Shift + Stroke Access Crisis00:44 Quick Intro + Industry Context01:05 Welcome to This Month in MedTech (LSI USA)02:00 Why Q1 2026 Feels Like a Turning Point03:10 M&A Surge: Boston Scientific, Medtronic, J&J Moves04:00 Macro Snapshot: Precision Over Scale Investing04:51 “Pragmatic Growth” Trend Explained06:05 Early-Stage Reality Check for Founders06:57 Commercial Validation Is Now Mandatory08:24 Why Startups Fail (It’s Not the Product)10:48 Investors Shift: “Who Will Actually Buy This?”11:15 TAM vs Reality: What Actually Matters15:12 Stryker vs Think Surgical Competitive Tension16:00 Why Smaller, Faster Robots Are Winning17:14 Shift to ASCs (Ambulatory Surgery Centers)18:00 Neurovascular Arms Race Begins19:22 Stroke Market Opportunity Explained20:32 Robotics Entering Stroke Care21:12 Fastest Growing Category: Thrombectomy22:20 Stroke Stats That Matter (Access Problem)24:06 Future of Stroke Clinics + Infrastructure Play25:34 Quantum Surgical + New Wave Deal Breakdown26:30 Why This Acquisition Is Strategic Gold32:02 Conformal Medical Acquisition Explained33:22 Why M&A Momentum Matters for MedTech33:54 VB Spine + AR Navigation Play35:23 Why Spine Innovation Is Back41:09 Heart Failure: The Next Big Opportunity42:00 Boston Scientific Goes All-In on Neuromodulation43:16 Key Insight: Winning = Positioning, Not Product44:31 Why 2026 Is a “Move Fast” Year45:00 Compass AI + Data-Driven Decision Making46:11 LSI Event Insights + Industry Direction47:35 What This Means for the Rest of 202648:16 Outro + Subscribe CTAAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateebThis podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions#medtech #healthtech #medicalinnovation #startupgrowth #healthcareinvesting

In this episode, Omar Khateeb speaks with Sean O'Mara, Founder and Senior Physician Researcher at Private Medical Research Practice, and Daniel J. Durand, Chief Medical Officer and President of Prenuvo Medical Group, about one of the biggest shifts happening in medicine today: the move from reactive care to proactive imaging.They discuss why whole body MRI is gaining attention, how early imaging can catch dangerous pathology before symptoms appear, and why traditional healthcare often misses serious issues until they become much harder to treat.The conversation covers visceral fat, pancreatic cancer, fatty liver disease, preventive screening, and why more patients are turning to advanced diagnostics outside the traditional insurance model.A deep and timely conversation for anyone interested in longevity, health optimization, early detection, and the future of preventive medicine. Episode Breakdown:00:00 Introduction and Why This Conversation Matters01:35 The MRI Debate That Sparked Everything04:10 Why Most Diseases Are Caught Too Late07:22 Reactive Healthcare vs Preventive Medicine10:05 What Whole Body MRI Actually Reveals13:18 The Truth About Annual Checkups16:40 Why Blood Work Misses Critical Problems19:55 Visceral Fat The Hidden Health Risk23:20 How Fat Distribution Predicts Disease26:45 Why Lean Does Not Mean Healthy30:10 Fatty Liver Disease Most People Don’t Know They Have33:40 The Link Between Obesity and Cancer Risk56:45 The Shift Toward Longevity Driven Healthcare01:00:10 AI in Imaging and What It Actually Improves01:03:25 The Limits of AI in Diagnosis01:06:40 What Doctors Still Do Better Than Machines01:09:55 The Future of Preventive Health Systems01:13:20 Who Should Actually Get an MRI01:16:05 Risks, Tradeoffs, and Overdiagnosis01:18:10 Final Thoughts on Early Detection and LongevityWant to actually see what’s happening inside your body?Get your MRI read with $1000 off using code OMAR:https://www.growingbetternotolder.com/ultimatestartAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateebThis podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions#medtech #preventivehealthcare #longevityscience #earlydetectionmatters #visceralfat

Omar Khateeb speaks with Eric Jorgenson, CEO at Scribe Media and author of The Book of Elon, about how some of Elon Musk’s most important ideas were curated into a practical guide for builders and entrepreneurs.Eric shares his approach to capturing timeless insights from great thinkers and explains how books can turn powerful ideas into tools for future innovators. They explore first principles thinking, mission driven entrepreneurship, and what founders can learn from Musk’s approach to building companies that change entire industries.A conversation about ideas, authorship, and why great books can shape how the next generation of builders think.Episode Breakdown:00:00 Introduction and Why Focus Matters More Than Time01:42 The Real Problem Founders Face04:10 First Principles Thinking Explained07:28 How Elon Musk Approaches Problems Differently10:52 Why Most People Work on the Wrong Things14:20 The Power of Clarity in Decision Making17:05 Turning Ideas Into Actionable Systems20:12 What Separates Builders From Thinkers23:40 Writing as a Tool for Clear Thinking27:18 How The Book of Elon Was Created30:05 Curating Ideas That Actually Matter33:22 Why Most Content Lacks Depth36:40 The Role of Mission Driven Thinking40:15 How Great Founders Stay Focused43:30 The Tradeoff Between Speed and Quality47:05 Lessons From Elon Musk’s Execution Style50:28 Why Constraints Create Better Outcomes54:10 The Importance of Long Term Thinking57:42 Building Products That Actually Matter01:01:10 Advice for Founders and Builders01:04:35 The Future of Publishing and Ideas01:08:00 How to Think Better and Build Smarter01:11:20 Final Thoughts and Key Takeaways Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateebThis podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions#medtech #foundermindset #elonmusk #startuplessons #buildinpublic

In this episode, Omar Khateeb, Founder of MarketCraft, explores the subtle but powerful skill of listening. While most people focus on how to speak better, persuade better, or present better, Omar explains why the true edge in communication often comes from learning when to stay quiet.He discusses why many conversations fail because people listen to reply instead of listening to understand, and how slowing down, asking better questions, and paying attention to what is not being said can completely change the quality of interactions.Omar also shares how listening plays a critical role in leadership, sales, entrepreneurship, and everyday relationships, and why the ability to truly hear others has become a rare but valuable skill in a noisy world.If you want to improve your communication, influence, and decision making, this episode offers a powerful reminder that sometimes the most impactful thing you can do is simply listen.Episode Breakdown00:00 Introduction00:42 Why Listening Is a Rare Skill Today01:28 The Problem With Talking Too Much02:12 Listening vs Waiting Your Turn to Talk03:08 The Subtle Art of Shutting Up04:02 Why Most People Don’t Feel Heard04:58 Listening as a Leadership Skill06:05 The Difference Between Hearing and Understanding07:10 How Great Operators Use Listening08:18 The Business Advantage of Listening First09:27 What Happens When You Actually Let People Talk10:34 Listening in Sales and Relationships11:42 Why Silence Creates Better Conversations12:48 How Listening Builds Trust Faster13:55 The Ego Problem in Conversations15:05 Learning to Slow Down and Observe16:10 Practical Ways to Become a Better Listener17:18 Why Listening Changes How People See You19:00 Final Thoughts on the Power of ListeningAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateebThis podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions#medtech #leadershipskills #communicationskills #listeningskills #businessleadership #personaldevelopment

In this episode, Omar Khateeb speaks with Abby Hunter-Syed, Director at Olympus Innovation Ventures, about how corporate venture capital is accelerating MedTech innovation. Abby shares how they invest in early-stage healthcare startups across endoscopy, diagnostics, GI health, and digital health, and how corporate venture helps founders navigate clinical validation, regulatory approval, and commercialization. They also discuss how investors evaluate early-stage MedTech companies and the signals that indicate future success.Episode Breakdown: 00:00 Intro and Today’s Topic01:08 Meet Abby Hunter-Syed and Olympus Innovation Ventures02:16 Abby’s Non-Linear Career Path into Venture Capital04:00 Why MedTech Innovation Is Accelerating05:18 Device Interventions vs Lifelong Pharmaceuticals06:36 GLP-1 Drugs vs Bariatric Procedures16:07 Are New Strategic Buyers Changing MedTech Investing?17:51 Going Earlier vs Writing Bigger Checks in MedTech19:18 What Olympus Looks for in Startup Investments20:15 Why Transparency Matters Between Investors and Founders22:13 How Venture Firms Discover New MedTech Startups23:37 Corporate Venture Capital as a Service Explained24:34 The Hottest Innovation Areas in MedTech Right Now25:55 Why Colorectal Cancer Screening Needs Innovation26:30 Wearables and Preventive Healthcare Trends27:43 Full Body MRI and Preventive Cancer Screening30:16 New Consumer Health Technologies and At-Home Diagnostics32:33 Early Signals That Predict Startup Success34:33 Why Investors Hide Behind “Come Back When You Have Revenue”36:00 The Importance of Founder Conviction38:43 Why MedTech Struggles to Attract Talent and Capital40:43 The Real Challenges of Building MedTech Companies41:50 Regulatory and Reimbursement Barriers in Healthcare43:37 Paying Cash for Healthcare and New Consumer Models46:49 Advice for MedTech Founders48:27 Final Thoughts and Episode Wrap UpAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateebThis podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions#medtech #healthcareinnovation #corporateventure #healthtech #startupinvesting

In this episode, Omar Khateeb sits down with Jake Ghannam, Executive Vice President and Chief Commercial Officer at INSIGHTEC, to discuss how a breakthrough neurosurgery technology is redefining treatment for patients with severe tremors and neurological disorders.Jake explains how INSIGHTEC is building a global platform around incisionless brain surgery and what it takes to commercialize a complex medical innovation in highly regulated healthcare markets. He also shares lessons from his career journey, from selling medical devices in operating rooms to leading the commercial strategy for one of the most innovative companies in medtech.They explore the realities of scaling global medtech companies, the importance of talent and leadership in healthcare innovation, and why focus and execution are critical when bringing life saving technologies to market.If you are interested in medtech innovation, commercialization strategy, and the future of neurosurgery, this episode offers deep insight into how groundbreaking technologies become real world solutions for patients.Episode Breakdown:00:00 Incisionless Brain Surgery That Stops Tremors01:05 Introduction to the Episode and Guest08:15 Seeing Patients’ Tremors Stop in Real Time10:20 The Origin Story of Insightec13:05 Why This Technology Is a Neurosurgery Moonshot15:10 How Focused Ultrasound Works Inside the Brain17:40 The Science of Delivering Acoustic Energy Safely35:00 Why This Technology Is Changing Neurosurgery38:05 Challenges of Bringing New MedTech to Market41:00 FDA Approvals and Regulatory Milestones43:45 Adoption by Hospitals and Neurosurgeons46:30 The Future of Focused Ultrasound in Medicine49:15 Expanding Treatments Beyond Movement Disorders58:00 The Long-Term Vision for Insightec01:01:00 Advice for Founders Building Medical Technology01:03:20 Final Thoughts on the Future of Neurosurgery01:05:10 Outro and Where to Follow the ShowAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateebThis podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions#medtech  #medtechinnovation #parkinsonstreatment #neurosurgery #healthcareinnovation 

In this episode, Omar Khateeb sits down with Daniel J. Durand, CMO and President at Prenuvo, to discuss how whole body MRI and advanced imaging are redefining preventive healthcare. Daniel shares why most life threatening diseases like cancer are still detected too late, and how proactive full body screening can uncover risks before symptoms ever appear.They explore the role of AI in radiology, the economics of early detection, and how shifting from reactive care to predictive care could reduce long term healthcare costs while saving lives. If you are interested in health tech innovation, longevity, and the future of early diagnosis, this conversation delivers deep insight into where medicine is heading next.Episode Breakdown00:00 Introduction: The Gap Between Advanced Tech and Outdated Healthcare Systems01:00 Why Whole-Body Scanning Is Getting Attention in Healthcare03:15 How Prenuvo Is Rethinking Preventive Medicine06:10 The Problem With Traditional Medical Screening09:00 What a Full-Body MRI Actually Detects12:10 Why Early Detection Changes Patient Outcomes15:05 Inside Prenuvo’s Technology and Imaging Approach18:40 How the Clinics Operate and What the Patient Experience Looks Like22:10 The Economics of Preventive Imaging25:30 Who Should Actually Get a Full-Body Scan29:15 Concerns From the Medical Community33:20 The Data Challenge in Modern Healthcare37:00 AI, Imaging, and the Future of Diagnostics41:10 Building a New Category in Preventive Health45:20 Scaling Clinics and Expanding Access49:10 Lessons From Building a Health Tech Company53:00 Where Preventive Medicine Is Headed Next57:00 The Future of Full-Body Scanning and Early Detection01:01:00 Closing Thoughts and TakeawaysAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateebThis podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions#medtech #healthcareinnovation #healthtech #preventivemedicine #medicalinnovation

In this US Surgical Series episode, Joe DeVivo, President, CEO, and Chairman at Butterfly Network, joins Omar Khateeb to connect the legacy of Leon Hirsch and US Surgical to the future of handheld ultrasound.Joe shares how the relentless execution culture of US Surgical shaped his leadership philosophy and how that same discipline is driving Butterfly’s mission to democratize imaging. From collapsing ultrasound onto a single semiconductor chip to unlocking point of care diagnostics anywhere in the world, he explains why access to imaging fundamentally changes patient outcomes and clinical decisions.This conversation bridges medtech history and the next wave of scalable, AI powered diagnostics.Episode Breakdown:00:00 – Intro: Why this MedTech story matters02:11 – Joe DeVivo’s background & early career path05:04 – Lessons from early leadership roles07:52 – Entering surgical robotics10:36 – Scaling inside complex healthcare markets13:18 – What makes surgical platforms powerful16:02 – Competition in MedTech: Then vs now18:47 – Building durable advantages in regulated industries21:31 – The evolution of Intuitive Surgical24:18 – Capital intensity & long-term thinking27:02 – Leadership under pressure29:46 – Managing innovation inside large organizations32:33 – Distribution, training & surgeon adoption35:19 – Platform strategy in surgical robotics38:04 – The economics behind robotic surgery49:05 – Where robotics is actually headed51:49 – Building teams in high-stakes environments54:36 – Product-market fit in healthcare01:08:20 – What separates great CEOs01:11:05 – Advice for founders entering healthcare01:13:50 – The future of surgical robotics01:16:34 – Personal reflections & career lessons01:19:18 – Long-term industry outlook01:22:03 – Rapid-fire insights on leadership & growth01:24:47 – Final thoughts on building enduring companies01:27:32 – Closing reflections01:30:16 – Key takeaways from the conversation01:37:00 – OutroAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateebThis podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions#medtech #healthcareinnovation #surgicalrobotics #medicaldevices #healthcareleadership #surgicalinnovation

In this episode, Chuck Vivian,Experienced Commercial Executive and Advisor Medical Devices, sits down with Omar Khateeb to unpack the rise of US Surgical during the laparoscopic revolution. He shares firsthand stories from the operating room, the pressure of never missing quota, and the training culture that demanded excellence without excuses. Discover how US Surgical built momentum through surgeon partnerships, how the competitive battle reshaped the industry, and why process discipline often beats raw talent. Chuck also reflects on the leadership lessons he carried from field rep to executive, offering insight into building resilient, high performance teams in medical devices.Episode BreakDown:00:00 Introduction: The Intensity of US Surgical Training00:47 Meet Chuck Vivian: Early Life in Chicago04:30 The Inflection Point: Discovering Ambition at 1707:45 Breaking Into Medical Sales at American Hospital Supply11:20 Hustle Stories: Sneaking Into Hospitals to Win Business15:02 Joining US Surgical: The Last Training Class of 198416:36 Surviving the Norwalk Training Gauntlet23:08 Field Expectations: Process Over Personality28:21 Accountability Culture: What Real Leadership Looked Like32:15 Rising Through the Ranks to VP of Sales35:10 The Laparoscopic Revolution: Introducing the SurgePort Trocar40:00 Media Explosion and The Billion Dollar Breakthrough42:37 From Market Leader to Market War: The Ethicon Battle Begins49:10 Competing in the Staple Wars: Creativity and Survival55:40 Saving Kaiser Permanente: Listening as a Strategy01:01:38 Intuitive Surgical and the Second Battle01:06:45 Legendary Salespeople and What Made Them Elite01:10:30 Final Reflections: Culture, Mr. Hirsch, and Legacy01:12:00 Closing ThoughtsAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateebThis podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions#medtech #healthcareinnovation #surgicalrobotics #medicaldevices #healthcareleadership #surgicalinnovation

In this episode, Tony Recupero, Board Member of Recupero Strategic Advisory, LLC and TrackX Technology, Inc., joins Omar Khateeb to unpack the culture that defined US Surgical. He shares how a blue collar kid from upstate New York entered the operating room and was forged through one of the toughest training programs in medical device sales. Learn how six weeks of relentless preparation, daily accountability, and extreme performance standards built leaders who went on to shape the medtech industry. Tony also breaks down the importance of organic business growth, why short term sales tactics can backfire, and how high expectations can either break you or elevate you.Episode BreakDown:00:00 – Recruiter pitch: “How do you feel about the OR?”  01:18 – Intro: Tony Recupero and his start at US Surgical (1987)  02:10 – From consumer product sales to MedTech opportunity  09:25 – Daily quizzes, weekly exams, and memorized pitches  10:55 – Why scripted pitches worked in high-stress OR selling  11:57 – Learning procedures, all-night prep, and manager “pop quizzes”  14:10 – The “unnecessary stress” and scrubbing into surgeries  15:40 – OR culture then vs now and the risks of reps touching anything  17:08 – How extreme expectations shaped leaders (and broke some people)  18:10 – Leadership lesson: high standards without crushing reps  19:20 – Mentors and names that shaped his sales leadership style  21:40 – The standout leader: two styles of coaching and accountability  23:32 – Most painful moment: missing quota for the first time  24:10 – Two-room quota culture: winners vs missers  26:10 – Why he missed: territory was stuffed with inventory before him  27:05 – The real lesson: build organic usage, don’t rely on big stocking orders  29:10 – Activity drives results: “Do the right activities and numbers follow”  30:45 – Best memories: promotions, $50M Tenet deal, MVP from Leon Hirsch  31:55 – Closing: gratitude, legacy, and wrap-upAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateebThis podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions#medtech #healthcareinnovation #surgicalrobotics #medicaldevices #healthcareleadership #surgicalinnovation